Skip to main content
Toggle navigation
Login
Home
Browse by Poster Title
Home
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
1
(A-199)
(A-199) 10 Practical considerations for the conduct of multinational studies in pharmacoepidemiology
Favorite
2
(A-339)
(A-339) 2024 interim results from the VAC4EU post-authorisation safety study (PASS) for the Pfizer-BioNTech COVID-19 vaccine (Comirnaty®) in Europe
Favorite
A
(C-242)
(C-242) A Broad Scan of Associations between Doxycycline and Congenital Malformations Using a Tree-based Data-mining Approach
Favorite
(A-262)
(A-262) A Case of Periocular/Palpebral Allergic Reaction due to Bepotastine Besilate Ophthalmic solution
Favorite
(A-270)
(A-270) A Collaboration to Explore and Compare Existing Tools for Retrieving Pregnancy Reports from VigiBase
Favorite
(A-326)
(A-326) A Collaborative Approach to Evaluate Risk Factors for a Rare Adverse Event Among Individuals with Multiple Sclerosis Exposed to Sphingosine 1-phosphate Receptor Modulators
Favorite
(C-202)
(C-202) A Comparative Analysis of Premarket and Postmarket Safety Data Between Non-Oncology Externally Controlled and Internally Controlled Orphan Drug Approvals
Favorite
(A-123)
(A-123) A comparative efficacy of anti-fibrotic drugs on NASH: A systematic review and Network meta-analysis
Favorite
(B-139)
(B-139) A comparative evaluation of potential rivaroxaban drug interactions from four database programs
Favorite
(SLC-004)
(SLC-004) A Comparative Study of Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors on Renal Disorders in Type 2 Diabetes Mellitus
Favorite
(C-165)
(C-165) A Comparison of Concept Completeness in Single-Network and Multi-Site Approaches to Real-World Data Collection
Favorite
(A-057)
(A-057) A Course of Medication in Patients with Rheumatoid Arthritis and Their Comorbidities in Japan: a Descriptive Analysis Using Japanese Claims Data
Favorite
(A-020)
(A-020) A cross-sectional analysis of Patient-Reported Outcomes collection in registries indexed in the Heads of Medicines Agencies-European Medicines Agency Catalogues of Real-World Data Sources and Studies
Favorite
(SLB-060)
(SLB-060) A Cross-Sectional Study of Race and Ethnicity Reporting and Representation among Cancer Patients in Select US Real-World Data Sources
Favorite
(SLB-033)
(SLB-033) A drug utilization study of Z-drug within psychiatric outpatients in regional hospital during the era of post-pandemic
Favorite
(B-197)
(B-197) A Fair Individualized Risk Score for Identifying Risks of Falls among Patients with Alzheimer Disease and Related Dementia
Favorite
(A-055)
(A-055) A Feasibility Study of Identifying Patients with Chlamydial Infections in a US Claims-Based Database
Favorite
(C-162)
(C-162) A Fitness-for-use Assessment of Real-World Data Sources and Data Linkage to inform a Post-Authorization Safety Study - A Formalized Feasibility Study
Favorite
(C-199)
(C-199) A Framework for Combining Diverse and Complementary Datasets to Create External Comparator Arms
Favorite
(SLC-012)
(SLC-012) A Framework to Detect and Quantify Operator-Learning Effects in Medical Device Safety Evaluation
Favorite
(SLA-067)
(SLA-067) A fully automated AI-enabled pipeline for extracting Kaplan-Meier survival data from scientific plots
Favorite
(C-185)
(C-185) A Learning Healthcare Initiative: Real Time Medication Use Evaluation of Lecanemab-irmb and Donanemab-azbt - Surveillance of Mild Cognitive Impairment/Alzheimer’s Disease in the Veterans Health Administration
Favorite
(C-129)
(C-129) A Machine Learning Approach for Identifying Patients with Unmet Health-Related Social Needs from EHR data
Favorite
(B-023)
(B-023) A novel salivary-based companion diagnostic device for early detection and monitoring of HER-2+ breast cancer patients in resource-limited settings
Favorite
(SLC-051)
(SLC-051) A Pregnancy Registry to Evaluate the Safety of CYD Tetravalent Dengue Vaccine among Inadvertently Exposed Pregnant Women and their Offspring
Favorite
(C-023)
(C-023) A Profile Study of Characteristics and Treatment of Preterm and Term Births in the United Sates: An Analysis of the CDC WONDER Database, 2016-2023
Favorite
(A-264)
(A-264) A Proposed Framework to Leverage TreeScan Methods in Real-World Data for Signal Detection
Favorite
(B-154)
(B-154) A Qualitative Study on Iatrogenesis: Perspectives from Healthcare Professionals
Favorite
(SLB-017)
(SLB-017) A real-world database study of myelodysplastic syndrome and acute myeloid leukemia in prostate cancer patients
Favorite
(B-034)
(B-034) A Retrospective Cohort Analysis of the Prevalence of Hypertrophic Cardiomyopathy in the US Pediatric Population
Favorite
(C-241)
(C-241) A Retrospective Cohort Study of Sarcopenia in Patients with Type 2 Diabetes Mellitus treated with SGLT2 Inhibitors and Other Antihyperglycemic Agents
Favorite
(C-028)
(C-028) A Retrospective, Non-interventional Cohort Study of Visual Acuity Changes in Patients with Interstitial Cystitis Receiving Pentosan Polysulfate Sodium
Favorite
(SLB-016)
(SLB-016) A Scoping Review of the Benefits and Risks of Prescription Stimulant Medications in Older Adults
Favorite
(A-046)
(A-046) A Study of Granulocyte-Colony Stimulating Factor (G-CSF) Reference and Biosimilar Products using Real World Data to Emulate a Target Trial for Switching: A Biologics and Biosimilars Collective Intelligence Consortium Experience
Favorite
(A-273)
(A-273) A Ten-year Record Analysis of Acute Poisoning in a Tertiary Hospital, Nigeria
Favorite
(C-101)
(C-101) A time-trend analysis of psychotropic drug prescription patterns in a Peruvian inpatient population during the COVID-19 pandemic
Favorite
(A-263)
(A-263) A Two-Year Review of Adverse Drug Events (ADEs) in Saudi Arabia: Trends and Pharmacovigilance Insights from 2023-2024
Favorite
(B-216)
(B-216) A Validation Study to Evaluate Code Based Definitions for Sickle Cell Disease, Genotypes, and Acute and Chronic Complications Using US Optum Electronic Health Records
Favorite
(A-229)
(A-229) A,B,Cs of ADCs (Antibody–Drug Conjugates) Post-Marketing Pharmacoepidemiology Planning
Favorite
(C-044)
(C-044) Accelerated Biological Aging and Postoperative Adverse Renal Events: A Multicenter Cohort Study
Favorite
(B-178)
(B-178) Accessing the Effectiveness of a Telephonic Medication Adherence Program among Medicare Members
Favorite
(B-210)
(B-210) Acetaminophen Use During Pregnancy and the Risk of Childhood Attention-Deficit/Hyperactivity Disorder (ADHD): A Quantitative Bias Analysis
Favorite
(B-235)
(B-235) Acid-Suppressive Medications and Risk of Childhood Asthma: A Meta-Analysis of Observational Epidemiological Studies
Favorite
(C-253)
(C-253) Active and Passive Safety Surveillance in Children Receiving Fluenz® Tetra Vaccination in England During Influenza Seasons - from 2014/2015 to 2022/2023
Favorite
(A-202)
(A-202) Active Safety Surveillance Using Real-world Evidence (ASSURE) Implementation: Transparent and Reproducible Real-World Evidence (RWE) Standardized Framework to Support Safety Signal Evaluation
Favorite
(C-042)
(C-042) Active Surveillance of Foodborne Diseases in the United States
Favorite
(C-041)
(C-041) Active Surveillance of Mosquito-borne Diseases in the United States
Favorite
(C-045)
(C-045) Acute All-cause hospitalization following medically-attended acute gastroenteritis (AGE) and norovirus AGE among patients with underlying chronic conditions in the United States, 2022–2024
Favorite
(B-253)
(B-253) Acute fever-related infant outcomes following COVID-19 mRNA vaccination during lactation using a case-time-control design
Favorite
(B-212)
(B-212) Adaptive multi-wave sampling for efficient chart validation
Favorite
(A-102)
(A-102) Addressing methodological challenges in estimating treatment effects using external controls in rare disease clinical trials when controls cross over to open label treatment
Favorite
(B-275)
(B-275) Adherence to Recommended Antiviral Treatment Guidelines for COVID-19 and Influenza during Pregnancy
Favorite
(B-106)
(B-106) Adherence to risk minimization measures for alemtuzumab use in Multiple Sclerosis: a drug utilisation study in four European countries
Favorite
(SLA-005)
(SLA-005) Adherence Trajectories to Antipsychotic Medications Among South Carolina Medicaid Beneficiaries with Schizophrenia or Schizoaffective Disorder
Favorite
(SLA-062)
(SLA-062) Adjusting for residual confounding using high-dimensional propensity scores in a study of inhaled corticosteroids and COVID-19 outcomes
Favorite
(B-243)
(B-243) Adverse Drug Events (ADEs) Associated with Outpatient Antibiotic Fills to Children by Dentists, 2014-2019
Favorite
(A-227)
(A-227) Adverse Drug Events Associated with Pembrolizumab In Pediatric Oncology: Analysis of Global and Local Individual Case Safety Reports
Favorite
(SLB-039)
(SLB-039) Adverse Events Associated with Concomitant Use of Opioids and Psychotropic Medications
Favorite
(C-249)
(C-249) Adverse events following COVID-19 vaccination and SARS-CoV-2 infection in women of reproductive age, United States, 2021-2022
Favorite
(SLC-031)
(SLC-031) Adverse events of special interest (AESI) Following COVID-19 Vaccination in Children and Adolescents Aged 5–17 Years: A Retrospective Cohort Study in South Korea
Favorite
(C-225)
(C-225) Adverse events of treatment and characteristics of patients with multiple myeloma: a Brazilian historical cohort study
Favorite
(SLB-032)
(SLB-032) Adverse Outcomes Associated with High-Risk Medication Administered to Children during the Dental Visit, 2014-2020
Favorite
(B-271)
(B-271) Adverse Pregnancy and Birth Outcomes in Women with Biopsy-Proven MASLD: A Nationwide Cohort Study
Favorite
(A-228)
(A-228) Adverse Pulmonary Reactions Associated with Proteasome Inhibitors in Multiple Myeloma: A Disproportionality Analysis of the FDA Adverse Event Reporting System
Favorite
(B-157)
(B-157) Aetiology, Prevalence and Pharmacological Management of Rheumatoid Arthritis among geriatrics at Kenyatta National Hospital (2018-2022)
Favorite
(A-237)
(A-237) Age and multimodal safety assessments: limitations of spontaneous reports data and the importance of advancing age-based risk stratification capabilities in real world data
Favorite
(C-021)
(C-021) Age-Specific Associations and Attributable Burden of Risk Factors for All-cause and Cause-specific Mortality in Patients with Chronic Kidney Disease
Favorite
(C-065)
(C-065) Age-specific Drug Utilization Patterns Among Pregnant Women in Taiwan: A Nationwide Cohort Study
Favorite
(B-203)
(B-203) Aggregating and harmonizing registry databases for comparative analyses – lessons learnt
Favorite
(C-127)
(C-127) AI Trustworthiness: A Study on the Calibration of Large Language Models in Pharmacoepidemiology
Favorite
(B-152)
(B-152) AI-Assisted Medication Management: Reducing Risks and Costs in Hyper-Polypharmacy Patients
Favorite
(SLB-052)
(SLB-052) AI-assisted pharmacogenomics tool can assist in Sickle cell disease management and reduce treatment costs
Favorite
(B-040)
(B-040) Algorithmically Confirming Patients with Type 1 Diabetes Using Claims Data
Favorite
(C-171)
(C-171) Aligning Data Types with Research Needs: Insights from ISPE 2024 Oral Presentations by the IDSWG RWE sub-Team
Favorite
(C-112)
(C-112) Alignment Between Multiple Myeloma Line of Treatment Algorithms Developed for Structured Healthcare Data and an Oncology EHR
Favorite
(C-189)
(C-189) Amnesia Associated with Teriparatide Use: Signal Review
Favorite
(SLB-012)
(SLB-012) An Active-Comparator Restricted Disproportionality Analysis of Fluoroquinolone and the Risk of Panic Attacks
Favorite
(C-151)
(C-151) An algorithm for identifying observable medication time among US nursing home residents
Favorite
(C-081)
(C-081) An Algorithm for Mapping the Treatment Sequences of Patients with COPD: Development and Application in a Canadian Cohort.
Favorite
(A-177)
(A-177) An Alternative to Non-Responder Imputation for Study Participants with Missing Outcomes in Single-Arm Drug Effectiveness Studies: A Case Study in the CorEvitas Psoriasis Registry
Favorite
(C-179)
(C-179) An Evaluation Strategy to Assess Patient Engagement Quality, Impact, and Outcomes
Favorite
(A-201)
(A-201) An evidence base to support the establishment of a fit-for-purpose quality management system for secondary data pharmacoepidemiological studies
Favorite
(A-254)
(A-254) An Open Source Pipeline for Collaboration and Evaluation of Power in Tree-Based Scan Statistics Used in Pharmacovigilance
Favorite
(C-132)
(C-132) Analysis and Management of Computable Operational Definition (CODef) Concept Variation Based on a Large Real-World Studies Library
Favorite
(C-136)
(C-136) Analysis of risk factors associated with 12-month incidence of pseudarthrosis following lumbar spinal fusion
Favorite
(SLA-011)
(SLA-011) Analysis of Sex Differences in Potent P2Y12 Inhibitors among Asian Acute Coronary Syndrome (ACS) Patients
Favorite
(A-001)
(A-001) Analyzing Medication Adherence as a Mediator in Disease Management
Favorite
(B-252)
(B-252) Analyzing Neonatal Mortality: A Systematic Review of Observational Study Approaches
Favorite
(A-261)
(A-261) Anaphylaxis Risk Across Cephalosporin Generations and Cefaclor: Insights from a Nationwide Case-Crossover Study (2011–2023)
Favorite
(B-251)
(B-251) Andexanet Alfa and Potential Risk of Thrombotic Events
Favorite
(C-079)
(C-079) Antibiotic Prescribing Trends by Provider Specialty and Drug Class Before and During the COVID-19 Pandemic (2013-2022)
Favorite
(SLA-167)
(SLA-167) Antibiotic use and risk of inflammatory bowel disease in older adults: a nationwide self-controlled case series study
Favorite
(B-299)
(B-299) Antibiotic-Related Side Effects and Infusion Reactions in Hospitalized Bacteremia and Sepsis Patients: Essential Data for Clinical Trials and Safety Monitoring
Favorite
(A-138)
(A-138) Anticoagulation Therapy for Non-valvular Atrial Fibrillation in China, 2010-2022
Favorite
(SLB-055)
(SLB-055) Antidepressant Drug Switching in the Swiss population with a focus on Escitalopram and drugs with pharmacogenetic dosing guidelines: A drug utilization study using claims data
Favorite
(A-160)
(A-160) Antidepressant Use Among US Nursing Home Residents with ADRD in 2018
Favorite
(C-209)
(C-209) Antidepressant Use and Colonrectal Cancer Risk: A Systematic Review and Meta-Analysis
Favorite
(C-108)
(C-108) Antidepressant use in a nationally representative cohort of older adults: longitudinal use and polypharmacy
Favorite
(B-095)
(B-095) Antidiabetic drug utilisation after COVID-19 infection amongst patients with diabetes mellitus type 2: a retrospective cohort study from the UK
Favorite
(A-291)
(A-291) Antihypertensive medication use, type of hypertension, and risk of birth defects: Expanded results from the National Birth Defects Prevention Study (1997-2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014-2021)
Favorite
(B-167)
(B-167) Antihypertensive Treatment Persistence and Direct Medical Cost in Acute Coronary Syndrome Patients Post-Percutaneous Coronary Intervention: Insights from Indonesia
Favorite
(A-257)
(A-257) Antimuscarinic Medication Use and Risk of Glaucoma: A Literature Review and Disproportionality Analysis Using FAERS
Favorite
(B-116)
(B-116) Antipsychotic Use Before and After Foster Care Enrollment Among Youth in Medicaid
Favorite
(B-232)
(B-232) Antipsychotic use in youth and children: a cohort study from Catalonia (Spain) of treatment patterns
Favorite
(SLA-061)
(SLA-061) Antipsychotic-Induced Weight Gain (AIWG) Among Patients Attending a Psychiatric Clinic at the Lagos State University Teaching Hospital (LASUTH)
Favorite
(B-142)
(B-142) Antithrombotic Treatment after Left Atrial Appendage Occlusion in Older Atrial Fibrillation Patients
Favorite
(B-070)
(B-070) Applicability of Real-World Data for Healthcare Decision-Making: A Review and Comparison of Guidelines
Favorite
(A-289)
(A-289) Application of Administrative Claims-Based Algorithms to Characterize Pregnancy in Atherosclerotic Cardiovascular Disease or Likely Familial Hypercholesterolemia
Favorite
(C-123)
(C-123) Application of Artificial Intelligence (AI) and Machine learning (ML) in oncology drug development using real-world data: A Targeted Review
Favorite
(B-199)
(B-199) Application of methodological strategies to address unmeasured confounding in real-world vaccine safety and effectiveness study: a systematic review
Favorite
(SLC-040)
(SLC-040) Application of observational research methods to real-world studies for rare disease treatments: a scoping review
Favorite
(SLC-028)
(SLC-028) Application of Pharmacokinetic Models in Real-World Data to Estimate Therapeutic Concentration in Pediatric Pharmacoepidemiology
Favorite
(A-353)
(A-353) Application of the Actor-Partner Interdependence Model to Understand COVID-19 Vaccine Decision-Making among Adolescents and their Parents
Favorite
(SLA-065)
(SLA-065) Applications of Machine Learning in Epidemiologic Research Utilizing Administrative Claims and/or Structured Electronic Health Record Data
Favorite
(SLA-060)
(SLA-060) Are diabetes treatments and education associated with cognitive performance? A UK Biobank study on type 2 diabetes
Favorite
(B-162)
(B-162) Artificial Intelligence-Based Estimation of the CGI-I to Address Gaps in Real-World Data and Increase Study Sample Size
Favorite
(SLA-071)
(SLA-071) Assessing ChatGPT’s accuracy in identifying major psychotropic drug-drug interactions: a feasibility study
Favorite
(A-206)
(A-206) Assessing Core Competencies in Pharmacoepidemiology Training Programs: A Global Needs Assessment
Favorite
(C-255)
(C-255) Assessing Knowledge, Attitude and Practice on Human Papilloma Virus Vaccination Among Medical Students at the University of Nairobi
Favorite
(A-265)
(A-265) Assessing Study Feasibility Using Trends in the FDA PMR/PMC Database: 2020-2024
Favorite
(A-349)
(A-349) Assessing the Association Between COVID-19 Vaccination and Thrombotic Thrombocytopenia Syndrome (ATTEST Study): Analyses of English Data, 2020–2022
Favorite
(C-181)
(C-181) Assessing the Association Between Sertraline Use and Type 2 Diabetes Mellitus: Evidence from Real-World Data and Mendelian Randomization
Favorite
(B-067)
(B-067) Assessing the Impact of COVID-19 Lockdown on Methadone and Buprenorphine Prescriptions in England: An Interrupted Time Series Analysis
Favorite
(B-082)
(B-082) Assessing the Impact of Volume-Based Procurement on Antidepressant Accessibility and Inequality: A Four-City Cohort Study Using Drug Sales Data
Favorite
(B-214)
(B-214) Assessing the Incidence of Major Adverse Cardiovascular Events in Medicare Data during the COVID-19 Pandemic
Favorite
(B-200)
(B-200) Assessing the Potential Differential Impact of the COVID-19 Pandemic on Cardiovascular Incidence Rates in United States Claims Data
Favorite
(C-237)
(C-237) Assessing the Risk of Angioedema in Adult Sacubitril/Valsartan Users With Heart Failure: Results From a Post-Authorization Safety Study in Seven European Electronic Healthcare Databases
Favorite
(B-215)
(B-215) Assessing the Risk of Hormonal Contraceptive Failure in the Presence of Drug-Drug Interactions with CYP3A4 inducers
Favorite
(A-319)
(A-319) Assessing the Risk of Neurodevelopmental Disorders in Children Prenatally Exposed to β-Lactam Antibiotics
Favorite
(B-102)
(B-102) Assessment of Analgesic Utilization and Quality of Life in Cancer Patients: A cross-sectional survey
Favorite
(SLB-049)
(SLB-049) Assessment Of Arsenic and Heavy Metal Contamination in Gallbladder Cancer: Carcinogenic Risk and Implications For DALY, Quality of Life, and Treatment Survival
Favorite
(SLB-043)
(SLB-043) Assessment of Neurotoxicity, Cardiovascular Risk Associated with Arsenic Exposure in Endemic Areas of Bihar, India.
Favorite
(B-111)
(B-111) Assessment of Potential Drug-Drug Interactions Among Patients with Diabetes Mellitus and Hypertension
Favorite
(A-357)
(A-357) Assessment of the Risk of 32 Adverse Effects of Special Interest following COVID-19 Vaccination in the Whole French Population
Favorite
(A-345)
(A-345) Assessment of the Safety of Human Papillomavirus Vaccination in Japan: VENUS Study
Favorite
(B-105)
(B-105) Assessment of Utilization Patterns of New Molecular Entities Approved in 2022 using the Sentinel Distributed Database
Favorite
(C-210)
(C-210) Association Between 5alpha-Reductase Inhibitors and Incident Cancer in Patients with Benign Prostatic Hyperplasia: Evidence from a Matched Cohort Study
Favorite
(A-323)
(A-323) Association Between 5alpha-Reductase Inhibitors and Risk of Developing Parkinson’s Disease in Patients with Benign Prostatic Hyperplasia: Evidence from a Prospective Cohort Study
Favorite
(SLC-026)
(SLC-026) Association between antibiotic exposure and response to treatment of juvenile idiopathic arthritis
Favorite
(B-258)
(B-258) Association between cardiac congenital malformations and mothers’ drug use during pregnancy in Catalonia, Spain
Favorite
(A-282)
(A-282) Association between continued benzodiazepine use and pregnancy outcomes in women undergoing assisted reproductive technology
Favorite
(SLC-048)
(SLC-048) Association between COVID-19 and thrombotic events: using Super Learner algorithm combined with doubly robust methods.
Favorite
(A-314)
(A-314) Association between depression and use of sodium-glucose cotransporter-2 inhibitors using target trial emulation: population-based cohort study
Favorite
(A-077)
(A-077) Association between early methadone dose titration and opioid toxicity and discontinuation: A population-based cohort study
Favorite
(SLB-042)
(SLB-042) Association Between Gabapentinoid Use, Concurrent Opioid or Benzodiazepine Therapy, and Traumatic Fracture Risk in Older Adults: A Self-controlled Case Series and Case-Case-Time-Control Study
Favorite
(A-085)
(A-085) Association Between Metformin Use and Mortality Among Individuals With Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort Study
Favorite
(B-011)
(B-011) Association Between Non-adherence to Oral Anticancer Monotherapy in Clinical Trials (CTs) and Progression-Free Survival (PFS) in Patients (pts) with R/R Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
Favorite
(B-194)
(B-194) Association between older adults’ socioeconomic status and their healthcare experiences, preferences, and attitudes towards medications: A cross-sectional study in 14 countries
Favorite
(C-071)
(C-071) Association Between Opioid Use Disorder (OUD) Treatment Modalities and Opioid-Related Hospitalizations Among Medicare Beneficiaries
Favorite
(B-025)
(B-025) Association Between Perioperative Hemoglobin Transfusion Thresholds and Renal Adverse Events in Cardiac Surgery: A Regression Discontinuity Cohort Study of 10,337 Patients
Favorite
(C-005)
(C-005) Association between Sodium-Glucose Co-Transporter 2 Inhibitors and Risk of Post-Stroke Epilepsy
Favorite
(SLB-027)
(SLB-027) Association between traumatic brain injury and post-hospitalization opioid dose among prevalent opioid users
Favorite
(A-328)
(A-328) Association of Dexamethasone Prescription with Acute Kidney Injury among Hospitalized Children
Favorite
(A-050)
(A-050) Association of Glucagon-Like Peptide 1 Receptor Agonists with Cancer Risk in Older Adults with Type 2 Diabetes: A Target Trial Emulation Study
Favorite
(A-305)
(A-305) Association of Glucagon-like Peptide-1 Receptor Agonists with Acute Pancreatitis and Biliary Disease in Individuals with Diabetes and Obesity: A Propensity-weighted, Population-based Cohort Study.
Favorite
(C-038)
(C-038) Association of Hepatitis B Surface Antigen Loss (HBsAg) with Clinical Outcomes Among Patients with Chronic Hepatitis B Virus (HBV) Infection: A Retrospective Cohort Study in the United States (US)
Favorite
(B-002)
(B-002) Association of new-onset hypertension and its treatment with survival in cancer patients: A retrospective cohort study using electronic medical record data.
Favorite
(A-297)
(A-297) Association of Risk of Congenital Malformations and Neurodevelopmental Disorders in Offspring in Women Who Continued Antipsychotics (APs) During Pregnancy
Favorite
(SLB-053)
(SLB-053) Association of serum vitamin D status with VDR and CAMP gene expression and their influence on biofilm formation in diabetic foot patients
Favorite
(A-120)
(A-120) Association of SGLT2 Inhibitors and GLP-1 Receptor Agonists with the Risk of Parkinson’s Disease in Patients with Type 2 Diabetes: A Propensity Score-Matched Cohort Study
Favorite
(B-267)
(B-267) Associations between COVID-19 vaccination during pregnancy and postpartum and human milk feeding initiation and continuation
Favorite
(A-322)
(A-322) Associations between lisinopril and amlodipine use and risk of aneurysmal subarachnoid haemorrhage: A UK population-based cohort study
Favorite
(C-026)
(C-026) Atopic eczema and subsequent hospital-recorded diagnoses: an outcome-wide study
Favorite
(C-221)
(C-221) Atrial Fibrillation and Bleeding in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) on Ibrutinib vs Acalabrutinib: Role of Age, Frailty, and Anticoagulants
Favorite
(B-129)
(B-129) Attention-Deficit/Hyperactivity Disorder Medication Utilization Among U.S. Adults Ages 18-64 Years with Commercial Insurance or Medicare: Implications for Design of Inferential Safety Studies
Favorite
(A-351)
(A-351) Autoimmune Disease Risks Across COVID-19 Vaccine Platforms: A Population-Based Cohort Study in Taiwan
Favorite
B
(A-346)
(A-346) Background Rates of Adverse Events for Vaccine Safety Monitoring at Two Sentinel Hospitals in Addis Ababa, Ethiopia
Favorite
(C-073)
(C-073) Barriers and Facilitators to Deprescribing Opioids in High-Risk Older Adults: A comparison based on cirrhosis status
Favorite
(A-352)
(A-352) Barriers and Strategies to Improve Vaccine Adverse Events Reporting: Views from Health Workers and Managers in Northern Ghana
Favorite
(A-350)
(A-350) Baseline Characteristics of Patients Included in a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States: Results From an Interim Analysis
Favorite
(B-100)
(B-100) Bayesian Analysis of Factors Associated with Romosozumab Adherence Among Early Adopters in Medicare Beneficiaries
Favorite
(B-014)
(B-014) Bayesian Analysis of Linear Tumor Growth Rate: Case Study in VHL Disease
Favorite
(C-085)
(C-085) Belatacept Use Among U.S. Kidney Transplant Recipients (2011-2020)
Favorite
(A-170)
(A-170) Benzodiazepines Initiation During Pregnancy and the Risk of Adverse Neonatal Outcomes
Favorite
(C-148)
(C-148) Beyond Comparison: Target Trial Emulation (TTE) Principles Strengthen Observational Single-Arm (SA) Effectiveness Studies
Favorite
(A-143)
(A-143) Bias in Pharmacoepidemiological Studies of Parkinson’s Disease Prescribing Patterns: A Systematic Review
Favorite
(B-269)
(B-269) Bias induced by method of pregnancy identification in studies of prenatal exposures using administrative healthcare data
Favorite
(B-118)
(B-118) Bibliometric Analysis of Global Research Trends and Themes in ADHD
Favorite
(A-044)
(A-044) Biologic Therapy and All-cause Cancer Risk in Patients with Inflammatory Bowel Disease: A Nested Case-Control study
Favorite
(B-286)
(B-286) Bisphosphonate Use and the Risk of Inflammatory Eye Reactions: A Case-Crossover Study
Favorite
(B-289)
(B-289) Bleeding Risk During Use of Non-vitamin K Antagonist Oral Anticoagulants with Telmisartan versus Olmesartan in Patients with Non-Valvular Atrial Fibrillation
Favorite
(A-279)
(A-279) BOOST-HP DrugScan: Identifying Medications Associated with Pregnancy Loss
Favorite
(B-044)
(B-044) Buprenorphine and Methadone Initiation Among People with HIV and Diagnosed Opioid Use Disorder in a Clinical Cohort in Baltimore, Maryland
Favorite
C
(C-231)
(C-231) Calcium Supplements and the Risk of CVD Recurrence: Real-World Evidence
Favorite
(C-122)
(C-122) Can contemporary large language models provide the domain knowledge needed for causal inference?
Favorite
(SLA-037)
(SLA-037) Can observational studies replace experimental transition (or switching) studies for evaluating the interchangeability of biological drug reference and biosimilars? Methodological challenges and considerations
Favorite
(C-228)
(C-228) Cancer Treatment-Related Risk Factors for Stroke among Patients with Lung Cancer: A Systematic Review
Favorite
(C-247)
(C-247) Cannabis-Related Healthcare Encounters among Commercially Insured Adults Aged 18-64 Years Contributing Data to the US Food And Drug Administration’s Sentinel, 2017-2022
Favorite
(SLB-023)
(SLB-023) Cardiovascular Adverse Events of Endocrine Therapies in Women with Breast Cancer: A Disproportionality Analysis Using FAERS
Favorite
(SLA-034)
(SLA-034) Cardiovascular Disease Risk Among Patients Using Tumor Necrosis Factor-Alpha Inhibitors and Milk Consumption: A Population-Based Study
Favorite
(A-147)
(A-147) Cardiovascular, Kidney, and Safety Outcomes following GLP-1 Receptor Agonist initiation in Adults with Alzheimer's Disease and Related Dementias: A Target Trial Emulation Study
Favorite
(B-176)
(B-176) Catheter ablation versus antiarrhythmic drugs for treatment of atrial fibrillation in patients with concomitant heart failure with preserved ejection fraction (HFpEF)
Favorite
(B-158)
(B-158) Central Nervous System (CNS) medication use patterns before suicide among older adults
Favorite
(B-223)
(B-223) Challenges and Learnings from a Prescription Sequence Symmetry Analysis Replication Study to Inform a Reusable Negative Control Programming Tool
Favorite
(B-161)
(B-161) Change in Healthcare Use Before and After COVID-19 Using Data From 1.5 Million Individuals in Sweden
Favorite
(B-113)
(B-113) Changes in Initial Maintenance Inhaler Regimens for Canadian Patients with Chronic Obstructive Pulmonary Disease from 2018-2023: A Multi-Province Analysis
Favorite
(B-031)
(B-031) Changes in Outpatient Care Utilization Among Medicare Beneficiaries with Atrial Fibrillation Following the Covid-19 Pandemic
Favorite
(C-017)
(C-017) Changes in the incidence of adverse events of special interest after diagnosis of COVID-19 between November 2020 and January 2024
Favorite
(C-066)
(C-066) Channeling Bias in First-Line Prescribing of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Individuals with Severe Mental Illness and Diabetes
Favorite
(B-108)
(B-108) Characteristics and Comorbidities of Amikacin Liposome Inhalation Suspension (ALIS) Initiators in U.S. Claims
Favorite
(SLC-036)
(SLC-036) Characteristics and mortality of patients with Pulmonary Arterial Hypertension in France: A 2010-2023 Nationwide Study from the French Health Data System (SNDS)
Favorite
(A-274)
(A-274) Characteristics of Drug Safety Alerts issued by two Latin American Drug Regulatory Agencies
Favorite
(B-032)
(B-032) Characteristics of Patients Initiating Glucagon-like Peptide-1 (GLP-1) Receptor Agonists (RAs) for Cardiometabolic Risk Reduction in a Medicare Population
Favorite
(B-033)
(B-033) Characteristics of Patients Initiating Wegovy (Semaglutide) for Cardiovascular Risk Reduction in a Medicare Population
Favorite
(B-079)
(B-079) Characteristics of RWE used in Regulatory Decision-Making for Marketing Authorization Applications (MAAs)
Favorite
(SLB-021)
(SLB-021) Characterization and Incidence of Breast Cancer Amongst Females in the United Kingdom: An Analysis of Real-World Data from THIN® UK Database and Comparability with Findings from the CPRD GOLD Database
Favorite
(C-060)
(C-060) Characterization of Adult Patients with Cystic Fibrosis in the TriNetX Linked EHR + Claims Network
Favorite
(B-226)
(B-226) Characterization of Confounding Covariate Data Capture in the U.S. Food and Drug Administration’s Sentinel Distributed Database
Favorite
(A-219)
(A-219) Characterization of Healthcare Providers of a Cohort of Patients from Claims Data Based on Propagated Information from Linkage to Patient Encounters
Favorite
(SLC-020)
(SLC-020) Characterization of Mothers in the Sentinel Distributed Database Mother-Infant Linkage Table
Favorite
(C-014)
(C-014) Characterization of the Alzheimer's Disease (AD) Population with Down Syndrome (DS) within England using electronic health records: a clinical practice research datalink study (CPRD) using AD algorithms
Favorite
(C-013)
(C-013) Characterization of the Alzheimer's Disease (AD) Population within England using electronic health records: a clinical practice research datalink study (CPRD) using AD algorithms
Favorite
(A-340)
(A-340) Characterizing background risk of febrile seizure among pediatric patients during routine clinical care and vaccination
Favorite
(C-105)
(C-105) Characterizing Demographics and Comorbidities for New Initiator GLP-1 Patients, 2016 – 2023
Favorite
(C-016)
(C-016) Characterizing dupilumab-naïve patients with bullous pemphigoid using US administrative claims data
Favorite
(B-193)
(B-193) Characterizing Latent Tuberculosis and Screening among Individuals diagnosed with Active Tuberculosis Disease in the United States
Favorite
(SLC-042)
(SLC-042) Characterizing Neuropsychiatric Adverse Events of Semaglutide Reported in FAERS: Analysis of Off-Label and On-Label Use
Favorite
(C-003)
(C-003) Characterizing Smoking Behavior from EMR-based Problem Text Strings in a U.S. Database to Inform Disease Prediction for Lung Cancer Detection
Favorite
(C-006)
(C-006) Characterizing treatment and burden of disease in adolescents with schizophrenia
Favorite
(C-223)
(C-223) Chimeric Antigen Receptor Therapy (CAR T) Therapy and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS): A Systematic Review and Meta-analysis
Favorite
(A-204)
(A-204) Clearing Real-World Data Quality Hurdles: Characterizing Quality Attributes of the Guardian Research Network in the Context of Regulatory Submission
Favorite
(B-164)
(B-164) Clinical and Cost Impact of Long COVID in the Medicare Population: A Self-Controlled and Propensity Score Matched Case-Control Study
Favorite
(SLC-016)
(SLC-016) Clinical and Economic Burden Associated with Complications Following Craniotomy: A Retrospective Database Analysis
Favorite
(B-165)
(B-165) Clinical and Economic Burden Associated with Dural Tears Among Patients Undergoing Spinal Discectomy: A Retrospective Database Analysis
Favorite
(SLC-014)
(SLC-014) Clinical and Economic Burden Associated with Dural Tears Among Patients Undergoing Spinal Fusion: A Retrospective Database Analysis
Favorite
(SLC-015)
(SLC-015) Clinical and Economic Burden Associated with Prolonged Air Leaks Among Patients Undergoing Lobectomy: A Retrospective Database Analysis
Favorite
(A-298)
(A-298) Clinical Characteristics and In-Hospital Outcomes of Infective Endocarditis Among Pregnant Women with Substance Use Disorders: A Nationwide Analysis
Favorite
(SLC-055)
(SLC-055) Clinical course and outcomes of myocarditis/pericarditis cases following mRNA-1273 vaccination compared to cases not following COVID-19 vaccination: interim analysis of a VAC4EU cohort study
Favorite
(SLC-013)
(SLC-013) Clinical Outcomes Among Patients Undergoing Lung Resection and Gastrointestinal Surgery Using Two Innovative Surgical Staplers in Routine Clinical Practice: A Multi-Institutional Database Study
Favorite
(A-196)
(A-196) Clinical trials with real-world pragmatic elements: A scoping review of use cases
Favorite
(B-099)
(B-099) Comedication Patterns of Romosozumab Early Adopters Among Medicare Enrollees: An Unsupervised Clustering Approach
Favorite
(B-012)
(B-012) Comorbidity Assessment using Integrated EHR and Claims in a National Oncology Database
Favorite
(A-127)
(A-127) Comparative 1‐Year Survival Among Hypertensive Alzheimer’s Disease Patients Receiving Donepezil Versus Memantine: A Target Trial Emulation Study
Favorite
(A-075)
(A-075) Comparative effectiveness and safety of fixed-dose combination inhaled triple therapies in patients with chronic obstructive pulmonary disease: a population-based cohort study
Favorite
(A-100)
(A-100) Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study
Favorite
(SLB-026)
(SLB-026) Comparative Effectiveness of Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma: An External Control Arm Study Using Lymphoma Registry
Favorite
(A-132)
(A-132) Comparative Effectiveness of Empagliflozin and Dapagliflozin in Patients with Heart Failure Without Diabetes: A Real-World Analysis
Favorite
(A-097)
(A-097) Comparative effectiveness of etelcalcetide versus cinacalcet for the treatment of secondary hyperparathyroidism in patients in haemodialysis: a population-based study in Lazio, Italy
Favorite
(A-078)
(A-078) Comparative Effectiveness of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Network Meta-Analysis
Favorite
(SLC-001)
(SLC-001) Comparative Effectiveness of Injectable Versus Oral Pre-Exposure Prophylaxis (PrEP) for HIV Prevention
Favorite
(B-268)
(B-268) Comparative Effectiveness of Nifedipine versus Labetalol in Pregnancy for Risk of Pregnancy Loss and Preterm Birth
Favorite
(C-141)
(C-141) Comparative effectiveness of robot-assisted radical prostatectomy versus open radical prostatectomy: a high dimensional propensity score matched cohort study within a nationwide claims database
Favorite
(A-118)
(A-118) Comparative Efficacy and Safety of Acalabrutinib Monotherapy in Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis
Favorite
(A-103)
(A-103) Comparative efficacy and safety of CFTR modulators for people with cystic fibrosis with phe508del mutation: a systematic review and bayesian network meta-analysis
Favorite
(B-172)
(B-172) Comparative Meta-Analysis of the Efficacy and Safety of Targeted Therapy and Immunotherapy Combined with Chemotherapy Versus Conventional Chemotherapy in Recurrent or Metastatic Head and Neck Cancer
Favorite
(C-236)
(C-236) Comparative Postoperative Outcomes and Utilization Trends of Transcatheter Aortic Valve Implantation vs. Redo Surgical Aortic Valve Replacement
Favorite
(B-180)
(B-180) Comparative Risk of Hip and Knee Arthroplasty Among Medicare Beneficiaries Initiating GLP-1 Receptor Agonists vs. SGLT2 Inhibitors
Favorite
(B-179)
(B-179) Comparative Risk of Hip Fracture Among Medicare Beneficiaries Initiating GLP-1 Receptor Agonists vs. SGLT2 Inhibitors
Favorite
(B-294)
(B-294) Comparative risk of hip fracture associated with initiation of Z-drugs among patients with and without osteoporosis
Favorite
(A-171)
(A-171) Comparative Risk of Preterm Birth Among Pregnant Individuals Treated for Urinary Tract Infection with Different Antibiotics
Favorite
(A-093)
(A-093) Comparative Safety and Effectiveness of Apixaban and Rivaroxaban for Treatment of Cancer-Associated Venous Thromboembolism: A Retrospective Cohort Study
Favorite
(B-008)
(B-008) Comparing approaches to real-world progression-free survival estimation among patients with advanced melanoma on first-line immunotherapy
Favorite
(A-149)
(A-149) Comparing cancer screening prevalence among older adults in Medicare Advantage encounter data and Fee-For-Service claims
Favorite
(C-130)
(C-130) Comparing Large Language Model Categorization of Nominal Group Technique Results to Human-Labeled Data in a Study on Juvenile Idiopathic Arthritis Treatment Change Preferences
Favorite
(C-018)
(C-018) Comparing Patterns of Hepatitis C Events by Treatment in Commercially-Insured Individuals with Opioid Use Disorder
Favorite
(A-281)
(A-281) Comparison of 4 algorithms to prospectively identify pregnancies in electronic health record data
Favorite
(B-255)
(B-255) Comparison of depression diagnosis and treatments during pregnancy from electronic health data with self-reported information
Favorite
(C-069)
(C-069) Comparison of Expenditure and Utilization of Top 25 High-Cost Drugs Across Canada and Comparable Countries
Favorite
(SLC-002)
(SLC-002) Comparison of Nephroprotective Effects Between Long- and Short-acting Angiotensin Receptor Blockers in Diabetic Nephropathy: A Real-world Retrospective Study
Favorite
(C-089)
(C-089) Comparison of Opioid Prescribing Before and After Onset of the COVID-19 Pandemic in the USA (2018-2022)
Favorite
(B-231)
(B-231) Comparison of prevalent new-user and sequential trial designs for studying the real-world effects of treatment discontinuation in cystic fibrosis
Favorite
(C-121)
(C-121) Comparison of Primary Care Coded Prevalence of Atrial Fibrillation and Prescribing Rates for Drugs Indicated for Atrial Fibrillation Identified Using a Large-Language Model
Favorite
(A-136)
(A-136) Comparison Of Tamsulosin And Dutasteride Combination Versus Silodosin And Dutasteride Combination In Patients With Benign Prostatic Hyperplasia
Favorite
(A-117)
(A-117) Comparison of the Hypocalcemia Risk between Denosumab and Bisphosphonates in Patients with Osteoporosis and CKD – A Target Trial Emulation Study Using Multi-Institutional Electronic Health Records
Favorite
(A-306)
(A-306) Comparison of the Pneumonia Risk Between GLP-1RAs and DPP4 Inhibitors in Taiwan
Favorite
(B-222)
(B-222) Comparison of time-to-next treatment and time-to-event endpoints using real-world data in checkpoint inhibitor-treated patients with advanced non-small cell lung cancer
Favorite
(C-188)
(C-188) Completeness of Spontaneously Reported Adverse Drug Reactions in Four Developed Countries.
Favorite
(C-254)
(C-254) Concomitant COVID-19 and Influenza Vaccination and the Risk of Psychiatric Adverse Events: a nationwide self-controlled case series study
Favorite
(SLB-022)
(SLB-022) Concordance between blinded independent central review committee and physician-assessed responses: Analyses based on a real-world external control arm in relapsed/refractory multiple myeloma using IMWG data
Favorite
(A-220)
(A-220) Concordance of Electronic Health Record Data and Medicare Part D Claims Data among Beneficiaries Prescribed Antihypertensive Medications
Favorite
(C-131)
(C-131) Conformal Prediction Framework and Selective Classification for Establishing the Credibility of Machine Learning Models – Application in Claims Data
Favorite
(C-027)
(C-027) Considerations for estimating prevalence and incidence based on systematic literature review: an example in geographic atrophy
Favorite
(B-149)
(B-149) Constructing a frailty index (FI) using the Behavioral Risk Factor Surveillance System: Application in lung cancer screening
Favorite
(B-125)
(B-125) Contact with the Health Care System Among Older Adults with HER2-Positive Metastatic Breast Cancer
Favorite
(C-135)
(C-135) Contemporary Trends in Catheter Ablation as First-Line Therapy Among Patients Diagnosed with Paroxysmal Atrial Fibrillation in Routine Clinical Practice in the United States
Favorite
(B-137)
(B-137) Contemporary Trends in Oral Anticoagulant Use Among Patients with Atrial Fibrillation and Cancer in UK Primary Care
Favorite
(A-076)
(A-076) Continuation versus discontinuation of SGLT2is and cardiorenal outcomes among patients with type 2 diabetes and chronic kidney disease: a nationwide cohort study with a target trial emulation framework
Favorite
(SLC-011)
(SLC-011) Contraceptive Utilization, Adherence, and Pregnancy Outcomes Among Active Duty Service Women
Favorite
(A-141)
(A-141) Contribution to the Development of the ATC/DDD Classification System from Italian Working Group on DDD: Assigning a Defined Daily Dose (DDD) to Anti-Angiogenic Drugs (ATC S01LA)
Favorite
(B-236)
(B-236) Correlation of Staphylococcus aureus (S. aureus) and Methicillin-resistant Staphylococcus aureus (MRSA) carriage in caregiver and children.
Favorite
(B-182)
(B-182) Cost-effective interventions to prevent prescription drug misuse: a systematic review
Favorite
(SLB-050)
(SLB-050) Costs and Coverage of Metered-Dose Inhalers and Sustainable Alternatives Among Older Adults in the United States
Favorite
(A-152)
(A-152) Costs and Lost Time for Employees whose Spouses have Dementia and/or Alzheimer’s Disease and Patient Direct Costs
Favorite
(C-067)
(C-067) COVID-19 Pandemic and Statin Adherence in Sweden: Insights from Cohort Analyses Before and During the Crisis
Favorite
(A-295)
(A-295) COVID-19 Vaccination Around the Time of Conception and Risk of Placenta-Mediated Adverse Pregnancy Outcomes
Favorite
(B-254)
(B-254) COVID-19 Vaccination During Pregnancy and Lactation and Infant Outpatient and Emergency Department Visits
Favorite
(SLC-056)
(SLC-056) COVID-19 vaccine effectiveness against Post COVID-19 condition among 1,292,557 individuals with pre-existing immunity against SARS-CoV-2: a population-based cohort study.
Favorite
(A-248)
(A-248) Critical Vs Major finding; According to the classification of MAH in Saudi Arabia
Favorite
(C-200)
(C-200) Current Status, Challenges and Opportunities in the Study of Minimum Data Set for Rare Diseases
Favorite
D
(A-324)
(A-324) DARWIN EU® - A multi-national network cohort study of the effect of doxycycline versus active comparators on the risk of suicidality in individuals with acne
Favorite
(C-047)
(C-047) DARWIN EU® - Characterisation and survival of elderly with recurrent falls in Europe
Favorite
(B-249)
(B-249) DARWIN EU® - Incidence of Myoclonus in Heart Failure: a Descriptive Analysis in Patients Treated with Sacubitril/Valsartan and Other Treatments
Favorite
(C-039)
(C-039) DARWIN EU® - Paracetamol overdose: a descriptive analysis of incidence rates and patient characteristics
Favorite
(B-134)
(B-134) DARWIN EU® - Paracetamol prescribing in Europe: a descriptive analysis of incidence and prevalence rates
Favorite
(C-087)
(C-087) DARWIN EU® - Prescription pattern of STOPP section K criteria medication in elderly with and without recurrent falls
Favorite
(B-003)
(B-003) DARWIN EU® - Prevalence of Frailty and Polypharmacy in Selected Cancers: results from Six European Countries in a Real-World Context
Favorite
(B-057)
(B-057) DARWIN EU® - Trends of use of Glucagon-like peptide-1 Receptor Agonists in real-world data from five European countries
Favorite
(B-058)
(B-058) DARWIN-EU ®- Antipsychotic prescribing in people with dementia in Europe: a descriptive analysis of trends and patient characteristics
Favorite
(SLB-058)
(SLB-058) Data Source Selection for Clinical Trial Diversity Planning: Rare Data in Rare Disease
Favorite
(SLA-059)
(SLA-059) Data stacking of RWD from two EMR Databases in the United States using Tokenization
Favorite
(C-198)
(C-198) Decoding IgA Nephropathy: Large Language Model-Powered Case Report Analysis of Etiologies and Sequential Treatment Strategies in Primary and Secondary Forms
Favorite
(A-133)
(A-133) Decreased Risk of Clinical Gallstone Disease in New-Users of Statins
Favorite
(B-209)
(B-209) Defining Cancer Outcomes Using Primary Care versus Hospitalization Data: A Case Study of GLP-1 RAs and Endometrial Cancer Incidence
Favorite
(C-012)
(C-012) Defining the prodromal phase in amyotrophic lateral sclerosis: a nationwide registry-based study
Favorite
(C-001)
(C-001) Denosumab Use and Cataract Risk in Patients with Osteoporosis: A Propensity Score-matched Cohort Study
Favorite
(A-337)
(A-337) Dependence of the Data Source on the Positive Predictive Value in the Retrospective Case Validation of Thrombosis and Thrombocytopenia Syndrome cases using Real-World Data
Favorite
(C-159)
(C-159) Description of chronic graft versus host disease using an innovative Artificial Intelligence Natural language processing on electronic medical records from 8 centers in France
Favorite
(SLC-010)
(SLC-010) Descriptive Evaluation of Neurovascular and Acute Myocardial Infarction Events with Different Pulsed-Field Ablation (PFA) Systems
Favorite
(A-027)
(A-027) Design and User-Testing of Digital Additional Risk Minimisation Material
Favorite
(B-150)
(B-150) Determinants Associated with Use of Angiotensin II Inhibiting vs Angiotensin II Stimulation Antihypertensive Medications among Medicare Beneficiaries
Favorite
(A-253)
(A-253) Determining Cardiovascular Safety Signals of Non-Steroidal Anti-Inflammatory Drugs: A Sequence Symmetry Study
Favorite
(A-343)
(A-343) Developing the Framework of Epidemiological and Biostatistical Approaches for Post-Approval Vaccine Safety Assessment Using a Large Healthcare Database in Japan: Year 1 Progress
Favorite
(A-209)
(A-209) Developing Validation Tool for Claim-Based Pregnancy Outcomes: The Pregnancy Algorithm CErtaInty Tool (Pregnancy ACE-IT)
Favorite
(SLA-064)
(SLA-064) Development and Use of a Novel Crosswalk to Evaluate Tablet or Pill Dosage Size in Real World Data
Favorite
(C-252)
(C-252) Development and Validation of a Machine Learning Model to Predict Rituximab-Induced Infusion Reactions in B-Cell Malignancy
Favorite
(A-208)
(A-208) Development and Validation of a Modern Prescription-Based Risk Score Predicting Healthcare Spending and Utilization
Favorite
(SLC-027)
(SLC-027) Development and Validation of a Nomogram for Predicting the Risk of Refractory Mycoplasma Pneumoniae Pneumonia in Children
Favorite
(C-061)
(C-061) Development and Validation of an N-gram Model for Differentiating between Melena and Hematochezia Using Unstructured Clinical Notes
Favorite
(A-213)
(A-213) Development and Validation of Claim-based Algorithms for Non-Melanoma Skin Cancer Using Optum Integrated Databases
Favorite
(B-221)
(B-221) Development and Validation of Identification Algorithms for Five Autoimmune Diseases Using Electronic Health Records: A Retrospective Cohort Study in China
Favorite
(B-217)
(B-217) Development and validation of the knowledge, attitude, and practice questionnaire for tuberculosis patients with type II diabetes mellitus: A study from India
Favorite
(C-176)
(C-176) Development and Verification of Robust Comprehensive Code Lists to Ensure Consistency Across Global Real-World Evidence Studies
Favorite
(B-260)
(B-260) Development of a Pregnancy Loss Risk Score to Address Potential Confounders for Pregnancy Loss
Favorite
(B-259)
(B-259) Development of an Infant Outcome Tree of Congenital Anomalies across ICD Eras
Favorite
(A-146)
(A-146) Development of Model for Predicting Early Mortality in Older Cancer Patients Treated with Chemotherapy
Favorite
(SLC-038)
(SLC-038) Diagnosis Patterns of Retinal Vasculitis in Real-World Data
Favorite
(C-009)
(C-009) Diagnostic Value of Thyroid-function Test, Fasting Lipid Profile and Hematological Parameters in Spontaneous Intracerebral Hemorrhage
Favorite
(B-151)
(B-151) Difference in Awareness of Osteoporosis and Bone Mineral Density Testing between Older Men and Women
Favorite
(B-069)
(B-069) Differences in Characteristics and Clinical Benefits of Pivotal Trials Supporting Regulatory Approval of “Breakthrough” Drugs in the US and China
Favorite
(A-148)
(A-148) Differences in the prevalence of diagnosis code groups for comorbidities using Medicare Advantage encounter data and Fee-For-Service claims
Favorite
(B-264)
(B-264) Differential regulatory approaches to the implementation of pregnancy registries between the United States and Europe
Favorite
(SLA-069)
(SLA-069) Digital data on the rise: What kinds of clinical trials are incorporating wearable devices
Favorite
(A-112)
(A-112) Direct Oral Anticoagulants and Incidence of Dementia in Patients with Nonvalvular Atrial Fibrillation
Favorite
(B-143)
(B-143) Discontinuation Pattern of Disease-modifying Therapies among Older Adults with Multiple Sclerosis
Favorite
(C-190)
(C-190) Disease burden and unmet needs of patients with amyotrophic lateral sclerosis in the United States
Favorite
(B-155)
(B-155) Disparities in Nonpharmacologic Chronic Pain Treatments for Older Adults with Alzheimer’s disease and Related Dementias
Favorite
(SLB-031)
(SLB-031) Disparities in the Utilization of Nirmatrelvir-Ritonavir in Taiwan: An Analysis Within a Universal Healthcare System During the COVID-19 Pandemic
Favorite
(A-269)
(A-269) Disproportionality analysis of reports of HIV resistance to integrase strand-transfer inhibitors from the WHO global safety database
Favorite
(A-268)
(A-268) Disproportionality analysis of sexual dysfunction reports related to integrase strand-transfer inhibitors: data from the FDA Adverse Reporting System - FAERS
Favorite
(C-216)
(C-216) Diuretics are associated with rates of basal and squamous cell carcinomas of the skin in the U.S. Medicare population with hypertension
Favorite
(B-159)
(B-159) Do GLP-1 RA medications change the rate of total knee and hip replacement surgeries? Comparing different GLP-1 RA medications as a proxy of their effect
Favorite
(C-035)
(C-035) Does COVID-19 relate to adverse maternal outcomes? Risk of cesarean section and preterm birth among Japanese women with COVID-19 during pregnancy.
Favorite
(C-250)
(C-250) Does exposure to metformin impact asthma-related outcomes and the risk of asthma-onset?
Favorite
(C-147)
(C-147) Does Health Plan Enrollment Data Support Long-term Follow-up of Patients with Chronic Disease? Assessment of the Healthcare Integrated Research Database (HIRD®)
Favorite
(C-137)
(C-137) Does the risk of readmission and revision events after lumbar spine fusion differ in hospital billing versus claims data?
Favorite
(A-113)
(A-113) Dosage adjustment pattern of renin-angiotensin system inhibitors in heart failure patients with severe renal dysfunction: A Nationwide Cohort
Favorite
(B-146)
(B-146) Double Burden: Anticholinergic and Sedative Medication Impact on Older Adults' Health Outcomes
Favorite
(A-244)
(A-244) Drug-Drug Interactions between Nirmatrilvir-Ritonavir and Cardiovascular Agents: A Scoping Review
Favorite
(A-048)
(A-048) Dupilumab Demonstrates a Higher Benefit-risk Score Compared with Upadacitinib: A Structured Benefit-risk Assessment of the HEADS UP Trial
Favorite
(SLA-002)
(SLA-002) Dynamic patterns of Antiretroviral Therapy Adherence among Newly Treated People living with HIV: a Group-Based Trajectory Modeling using Real-World Data in Belgium
Favorite
E
(SLB-029)
(SLB-029) Early Identification of Prodromal Symptoms for Multiple Sclerosis Risk Prediction Using Machine Learning Approaches
Favorite
(A-318)
(A-318) Early-life Antibiotic Exposure and the Risk of Neurodevelopmental Disorders: A Systematic Review and Meta-Analysis
Favorite
(SLA-039)
(SLA-039) Effect of Achieving Pain Relief between Baricitinib and Tofacitinib in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study using the TriNetX Global Collaborative Networks.
Favorite
(SLC-035)
(SLC-035) Effect of Anemia on Mortality in Janus Kinase Inhibitors Users with Myelofibrosis: A Nationwide Cohort Study
Favorite
(B-177)
(B-177) Effect of Antihypertensive Medications on Economic Burden Among Alzheimer’s Disease and Related Dementia Medicaid Beneficiaries in South Carolina
Favorite
(B-293)
(B-293) Effect of Cannabis on Renal Function in Patients Using Cannabis for Medical Purposes: A Longitudinal Cohort Study
Favorite
(A-087)
(A-087) Effect of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) in Alcohol Use Disorder: A Retrospective Cohort Study Using Electronic Health Records
Favorite
(A-081)
(A-081) Effect of Orlistat on Bodyweight Among Adults With Overweight or Obesity Without Diabetes: Emulation of a Target Trial Using UK Electronic Medical Records
Favorite
(A-222)
(A-222) Effect of Quercetin on inflammatory markers in Diabetes mellitus: a systematic review and meta-analysis of animal studies
Favorite
(B-104)
(B-104) Effect of Repurposing Antihypertensive Medications on Alzheimer’s Disease and Related Dementia Risks in South Carolina
Favorite
(A-155)
(A-155) Effect of statin discontinuation on mortality among older adults with and without cardiovascular disease
Favorite
(A-084)
(A-084) Effectiveness and Safety of Vortioxetine versus Other Antidepressants in Patients with Major Depression Disorder
Favorite
(A-109)
(A-109) Effectiveness and Tolerability of Cannabidiol in Children with Drug-Resistant Epilepsy: A Real-world Multicentric Ambispective Study in India
Favorite
(A-090)
(A-090) Effectiveness and waning of the fourth dose mRNA COVID-19 vaccines for the prevention of severe COVID-19 related outcomes
Favorite
(B-048)
(B-048) Effectiveness of an academic detailing service to support appropriate prescribing in patients with type 2 diabetes
Favorite
(A-099)
(A-099) Effectiveness of an intravenous amino acid treatment on outcomes in sepsis: a nationwide population-based cohort study
Favorite
(SLA-016)
(SLA-016) Effectiveness of Antipsychotics in Patients with Schizophrenia
Favorite
(SLC-050)
(SLC-050) Effectiveness of booster (third-dose) COVID-19 vaccination during pregnancy: a target trial emulation study using 4 European databases
Favorite
(SLC-021)
(SLC-021) Effectiveness of COVID-19 mRNA primary vaccination during pregnancy: a target trial emulation study using data from 4 European countries
Favorite
(C-010)
(C-010) Effectiveness of non-pharmacological interventions for insomnia in children and young adolescents with attention deficient hyperactivity disorder (ADHD): A systematic review and meta-analysis.
Favorite
(B-049)
(B-049) Effectiveness of Pharmacist-led Tele-Psychiatric Clinic in Managing Drug-Related Problems in Ambulatory Care Settings
Favorite
(SLA-166)
(SLA-166) Effectiveness, Safety, and Costs of Initiating Gabapentin Versus Pregabalin among Older Adults with Chronic Opioid Use
Favorite
(C-172)
(C-172) Effects of Biological Medication Exposure in Pregnancy and Neonatal Outcomes in Women with Autoimmune Diseases
Favorite
(A-114)
(A-114) Effects of Different Sedation Regimens on Mortality in Post-Cardiac Surgery Patients: A Target Trial Emulation Study
Favorite
(A-095)
(A-095) Efficacy and Safety of APOC3-Targeting Therapies, Olezarsen and Plozasiran in Severe Hypertriglyceridemia: A Meta-Analysis of Randomized Controlled Trials
Favorite
(C-226)
(C-226) Efficacy and Safety of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.
Favorite
(A-111)
(A-111) Efficacy and Safety of Pharmacological Interventions for Pulmonary Arterial Hypertension (PAH): A Systematic Review and Network Meta-Analysis (NMA) of Randomized Controlled Trials (RCTs)
Favorite
(A-116)
(A-116) Efficacy and Safety of PI3K/Akt/mTOR Inhibitors Combined with Taxane Therapy for Treatment of Breast Cancer: A Systematic Review and Meta-Analysis
Favorite
(A-094)
(A-094) Efficacy of SodiumGlucose Co-transporter2 Inhibitors in Patients with Heart Failure: An Open Labelled Randomized Study
Favorite
(A-205)
(A-205) Electronic Health Record (EHR) Enhanced Signal Detection Using Tree-Based Scan Statistic Methods
Favorite
(B-166)
(B-166) Employee Care Partners of Spouses with Parkinson's Disease: Analysis of Patient and Care Partner (Direct Medical, Rx, and Total) Costs and Care Partner Lost Work Time
Favorite
(C-233)
(C-233) Emulating a Clinical Trial to Assess the Fitness of Real-World Data for Evaluating the Cardiovascular Safety of Fixed-Dose Combination Naltrexone/Bupropion in the United States
Favorite
(C-114)
(C-114) Enhancing Pharmacy Practice: The Impact of Clinical Decision Support Systems in Reducing Drug-Related Issues
Favorite
(A-238)
(A-238) Enhancing Post-marketing Quantitative Signal Detection at GSK: A Comprehensive Review
Favorite
(SLC-018)
(SLC-018) Enhancing Pregnancy Drug Safety Studies: Expert Consensus on Methods and Definitions
Favorite
(A-272)
(A-272) Enhancing Safety Monitoring in Pharmacoepidemiology through High-Quality, Industry-Specific Translation Technology
Favorite
(A-240)
(A-240) Enhancing The Meaningfulness of Qualitative Adverse Event Report Reviews Through Incorporation of Quantitative and Qualitative Aspects of Causality Assessment
Favorite
(A-215)
(A-215) EpiCore - a common data model for Scandinavian pharmacoepidemiological studies
Favorite
(A-207)
(A-207) Epidemiologic Challenges in Using Claims Data to Study Opioid Use Disorder Treatment Trajectories
Favorite
(C-046)
(C-046) Epidemiology and Risk Factors for Antimicrobial Resistance in ICU Patients with Acinetobacter baumannii Infections: A Retrospective Study in an Indian Hospital
Favorite
(C-049)
(C-049) Epidemiology of intraoperative and postoperative complications in patients undergoing left-sided colorectal surgery for benign or malignant colorectal disease in England
Favorite
(B-184)
(B-184) Equity in Pharmacoepidemiology: Improving Understanding of Use, Benefits, and Risks of Medicinal Products in Human Populations
Favorite
(SLA-010)
(SLA-010) Erythropoiesis-stimulating agent and risk of osteoporotic fracture among chronic kidney disease patients: A territory-wide nested case-control study
Favorite
(A-249)
(A-249) Establishing a repository for background incidence rates of adverse events for use in safety signal assessment
Favorite
(SLC-033)
(SLC-033) Establishing standing cohorts of refractory lupus patients in the fit-for-purpose Real-World Data (RWD) sources to facilitate contextualization of upcoming clinical trial safety data: A feasibility project
Favorite
(A-195)
(A-195) Estimating artificial censoring weights for clone censor weighting studies: techniques and lessons learned
Favorite
(SLC-030)
(SLC-030) Estimating Chronic Kidney Disease Prevalence in the Pediatric Population in the United States Using Clinical Electronic Health Records (EHR) database
Favorite
(B-219)
(B-219) Estimating Health Care Contact Days for Medicare Beneficiaries Diagnosed with Metastatic Breast, Colorectal, Lung or Prostate Cancer, 2008-2019
Favorite
(B-190)
(B-190) Estimating Prevalence for 50 Common Nonfatal Health Conditions by Race/Ethnicity and County in the United States, Incorporating a Novel Correction for Healthcare Access Disparities
Favorite
(B-140)
(B-140) Estimating the burden of viral disease using the Comparative Risk Assessment framework from the Global Burden of Disease study – Two case studies assessing the impact of influenza and respiratory syncytial virus
Favorite
(C-029)
(C-029) Estimating the Effect of Hepatitis C on End-of-Treatment Outcomes Under Adequate Adherence to Strong Multidrug- and Rifampicin Resistant Tuberculosis Regimens
Favorite
(B-018)
(B-018) Estimating the incidence and prevalencehe incidence of second primary malignancy in men diagnosed with prostate cancer in the US during 2000-2022, as recorded in the US SEER 17 Registries
Favorite
(B-085)
(B-085) Estimating Travel Time and Spatial Access to Insulin in China Before and After National Volume-Based Procurement: A Geospatial Analysis
Favorite
(A-243)
(A-243) Ethambutol Under Scrutiny: Surge in Serious Eye Disorders
Favorite
(SLB-001)
(SLB-001) European perspectives on ethical aspects around utilization of patient registries for medicines decision-making
Favorite
(SLC-047)
(SLC-047) EU-Wide Survey on Key Stakeholders’ Knowledge, Opinions and Interests on Real-World Evidence in the Regulatory Process
Favorite
(C-146)
(C-146) Evaluating Cenobamate among patients with Focal-Onset Seizures: defining a claims-based approach for treatment regimen and outcomes
Favorite
(A-024)
(A-024) Evaluating Clinical Benefit and Regulatory Approval Patterns of Newly Approved Therapies for Multiple Myeloma: Is Brazil Keeping Pace with Global Advances?
Favorite
(A-124)
(A-124) Evaluating effectiveness of ibalizumab among highly treatment experienced people with HIV: an externally controlled trial
Favorite
(SLA-003)
(SLA-003) Evaluating Effectiveness of Risk Minimization Through Healthcare Professional Education: A Literature Review
Favorite
(SLA-013)
(SLA-013) Evaluating Mortality Risk and Post-discharge Antipsychotic Use in Patients with Hospital-Onset Delirium
Favorite
(A-203)
(A-203) Evaluating Result Consistency of OMOP and Sentinel Common Data Models: A Case Study of Hospitalized Atherosclerotic Cardiovascular Disease Patients in Taiwan
Favorite
(A-185)
(A-185) Evaluating Sequence Symmetry Analysis Across Six European Healthcare Databases
Favorite
(A-338)
(A-338) Evaluating the Diagnostic Accuracy of Adverse Events of Special Interest Following Janssen COVID-19 Vaccine (JCOVDEN) Using the VAC4EU Validation Pipeline
Favorite
(C-086)
(C-086) Evaluating the Impact of GAAT Criteria on the Development of Antimicrobial Resistance in ICU Patients Receiving Parenteral Antimicrobial Therapy
Favorite
(A-320)
(A-320) Evaluating the Impact of GLP-1RAs on Mental Health and Antidepressant Use: A Target Trial Emulation with Distributional NCO Calibration
Favorite
(B-038)
(B-038) Evaluating the Impact of Kidney Dysfunction on Cardiovascular Diseases Using the Global Burden of Disease Study
Favorite
(B-055)
(B-055) Evaluating the Implementation of Medication Adherence Interventions by Pharmacy-driven Living Labs in the Netherlands
Favorite
(SLB-037)
(SLB-037) Evaluating the Interaction between Antidepressants and Tamoxifen: Does Concurrent Use Adversely Affect Breast Cancer Outcomes?
Favorite
(C-116)
(C-116) Evaluating the Readiness of Saudi Oncology Real-World Data for Standardization and Quality Enhancement
Favorite
(C-227)
(C-227) Evaluating The Risk of Arrhythmias in Patients With COPD Treated With Aclidinium and Aclidinium/Formoterol and Other Inhaled Bronchodilators
Favorite
(C-230)
(C-230) Evaluating the Risk of Stroke among Female Patients using Osteoporosis Treatments
Favorite
(A-174)
(A-174) Evaluating the Robustness of Propensity Score Methods in Survival Analysis Under Sample Size Imbalance: A Monte Carlo Simulation
Favorite
(C-075)
(C-075) Evaluating treatment patterns in newly diagnosed Pulmonary Arterial Hypertension patients: First network study in PHederation, the Pulmonary Hypertension federated data network
Favorite
(B-211)
(B-211) Evaluation of a pregnancy algorithm using multiple data sources
Favorite
(A-247)
(A-247) Evaluation of Companies Pharmacovigilance Systems:Measuring Performance Before and After Exposure to Saudi regulatory PV Inspection Visits
Favorite
(B-169)
(B-169) Evaluation of completeness of patients’ follow up in a hospital healthcare database by matching with a closed claims database among atrial fibrillation patients
Favorite
(B-228)
(B-228) Evaluation of Database-Derived Real-World Disease-Free Survival (rwDFS) in Resected Non-Small Cell Lung Cancer (NSCLC)
Favorite
(A-235)
(A-235) Evaluation of Effectiveness of Additional Risk Minimisation Measures (aRMMs): perspectives from a UK non-interventional post authorisation safety study (PASS)
Favorite
(B-204)
(B-204) Evaluation of methods for quantitative bias analysis on the impact of unmeasured confounding during planning of a single arm trial with an external comparator arm
Favorite
(B-185)
(B-185) Evaluation of Productivity Losses Due to Premature Mortality from Head and Neck Cancer in Northeast India: a population-based cost analysis
Favorite
(B-080)
(B-080) Evaluation of Real-World Evidence in Regulatory and HTA Submissions
Favorite
(A-302)
(A-302) Evaluation of the Dorsata OBGYN EMR and Linked Infant Data for Use in FDA Pregnancy Safety Studies
Favorite
(B-051)
(B-051) Evaluation of the effectiveness of pregnancy prevention programme (PPP) for oral retinoids (acitretin, alitretinoin, and isotretinoin): a European before-after drug utilisation study (DUS) using secondary data
Favorite
(B-050)
(B-050) Evaluation of the implementation of medication adherence interventions in type 2 diabetes mellitus patients in Aruba and Curaçao: a mixed method study
Favorite
(A-303)
(A-303) Evolution of the treatment landscape for patients diagnosed with amyotrophic lateral sclerosis in the United States
Favorite
(B-077)
(B-077) Evolving Landscape of Post-Marketing Surveillance (PMS) Studies in Japan Utilising Secondary Real-World Data (RWD)
Favorite
(C-015)
(C-015) Examining the Association between Marijuana Use and Depression among U.S. Adults: An Analysis of NSDUH Data
Favorite
(C-208)
(C-208) Examining valproate’s potential anticancer effect among patients with bipolar disorder: a territory-wide active-comparator new user study spanning two decades
Favorite
(C-068)
(C-068) Expenditure and Utilization on GLP-1 Medications across High-Income Countries: A repeated cross-sectional analysis
Favorite
(A-181)
(A-181) Explainable Artificial Intelligence for Predicting Chemotherapy Toxicity: A Machine Learning Approach Using Pooled Clinical Trial Data
Favorite
(A-216)
(A-216) Exploring and Characterizing Glioblastoma Data from a Real-world Clinical Platform
Favorite
(C-164)
(C-164) Exploring Index Event and Channeling Biases in the Evaluation of the Impact of Prior PARP Inhibitor (PARPi) Exposure on the Efficacy of Subsequent Platinum-Based Therapy Among Patients (Pts) with Ovarian Cancer (OC)
Favorite
(A-193)
(A-193) Exploring methods for identifying heterogenous treatment effects (HTEs) for second-line type 2 diabetes medications and cardiovascular outcomes
Favorite
(SLA-058)
(SLA-058) Exploring the Association between Fluoroquinolones and Neuropsychiatric Adverse Events: A Scoping Review
Favorite
(B-303)
(B-303) Exploring the Impact of Implementing Automated Dispensing Cabinet Systems on Patient Safety and Human Resource Management in Inpatient Pharmacy Service at a Medical Center in Taiwan
Favorite
(C-022)
(C-022) Exploring the prognostic importance of serum phosphate levels and hyperphosphatemia on mortality and composite endpoints in non-dialysis CKD patients: a real-world evidence study
Favorite
(SLB-057)
(SLB-057) Exposure to multiple drugs with actionable pharmacogenetic biomarkers among older adults in China: A retrospective analysis
Favorite
(C-195)
(C-195) External Control Arm Studies in Marketing Authorisation Applications Submitted to the European Medicines Agency: A Review of Study Design Features and Methods
Favorite
F
(B-005)
(B-005) Factors Affected the Short-term Mortality in Patients with Non-Small Cell Lung Cancer
Favorite
(B-304)
(B-304) Factors affecting pharmacokinetics and dosing strategies of polymyxin B in multidrug-resistant gram-negative infected patients with renal impairment: A systematic review with expert opinion
Favorite
(B-041)
(B-041) Factors Associated with GLP-1 Receptor Agonist Utilization in Commercially Insured Patients with Diabetic Retinopathy
Favorite
(B-098)
(B-098) Factors linked to hospital-admission of chronic non-cancer pain patients prescribed long-term strong opioids
Favorite
(A-042)
(A-042) Faricimab Usage in Neovascular Retinal Diseases: Real-World Data on Patient Demographics, Comorbidities, and Treatment Patterns
Favorite
(C-248)
(C-248) FDA BEST IM Platform: Accelerating the Automation of Adverse Event Reporting
Favorite
(A-266)
(A-266) Feasibility Assessment of Using National Administrative Databases (SISPRO) to Support Post-Authorization Vaccine Safety Studies in Colombia
Favorite
(C-117)
(C-117) Feasibility assessments in federated networks of disease-specific harmonized data assets: best-practice recommendations based on the PHederation experience
Favorite
(C-158)
(C-158) Feasibility of Supplementing Single-Arm Trials with External Control Arms – Evaluation of German Real-World Data
Favorite
(C-173)
(C-173) Framework for Integrating Physician Stakeholder Feedback into Real-world Data Studies
Favorite
(C-124)
(C-124) Framework for Real-World Data Used in Regulatory Submissions
Favorite
(SLC-024)
(SLC-024) Frequent drug exposure during breastfeeding: a population-based cohort study with SIDIAP database.
Favorite
(B-074)
(B-074) From Catalogue to Clarity: Characterizing Chinese Data Sources for Post-Authorization Real-World Studies
Favorite
(C-119)
(C-119) From Guidelines to Practice: Regulatory Insights on Wearable Tech in Clinical Studies
Favorite
G
(B-281)
(B-281) Gabapentinoid Treatment, Concurrent Use with Opioid or Benzodiazepine and the Risk of Drug Poisoning: A Self-controlled Case Series Study
Favorite
(SLB-054)
(SLB-054) Genetically perturbed plasma sclerostin level and incident ischemic stroke
Favorite
(C-011)
(C-011) Geographic and Temporal Patterns of Psychotropic Prescriptions for Patients with Schizophrenia in Brazilian Public Healthcare System
Favorite
(C-048)
(C-048) Global Assessment of the Diagnosed Prevalence of Psoriasis and Plaque Psoriasis
Favorite
(C-051)
(C-051) Global Assessment of the Diagnosed Prevalence of Psoriatic Arthritis
Favorite
(C-220)
(C-220) Global Feasibility Assessment of Real-World Databases for Long-Term Safety of Vitiligo Treatments
Favorite
(A-126)
(A-126) GLP-1 Receptor Agonists and Risk of Osteoarthritis Among Patients with Type 2 Diabetes: A Population-Based Cohort Study
Favorite
(A-107)
(A-107) Glucagon-like Peptide-1 Receptor Agonists and Reduced Risk of New-Onset Atopic Dermatitis in Patients with Type 2 Diabetes: A Nationwide, Active-Comparator Study
Favorite
(A-309)
(A-309) Glucagon-like peptide-1 Receptor Agonists and the Risk of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes
Favorite
(A-098)
(A-098) Glucagon-Like Peptide-1 Receptor Agonists for the Prevention of Genitourinary Cancers: A Systematic Review of Observational Studies
Favorite
(A-304)
(A-304) Glucagon-like Peptide-1 Receptor Agonists vs. Sodium-glucose Cotransporter 2 Inhibitors and Risk for Dementia in Individuals with Diabetes: A Propensity-weighted, Population-based Cohort Study.
Favorite
(C-251)
(C-251) Glucosamine use and its causal effects on intraocular pressure: A Mendelian randomization study
Favorite
(B-094)
(B-094) Group-Based Trajectory Modeling to Assess Adherence to Chronic Urate-Lowering Therapies Among Commercially Insured US Adults with Gout
Favorite
(A-188)
(A-188) Group-Based Trajectory Models to Identify Potential Reasons for Treatment Switch Among Patients with Neovascular Age-Related Macular Degeneration (nAMD)
Favorite
H
(SLA-012)
(SLA-012) Handling Missing Laboratory Values across Various Missing Data Settings in Electronic Health Records
Favorite
(A-214)
(A-214) Harmonizing Electronic Health Records from Multi-Healthcare Systems in Saudi Arabia: A Comprehensive Guide with SQL Script
Favorite
(C-163)
(C-163) Harmonizing Standards: Recommendations for Mitigating Gaps in Real-World Evidence (RWE) Feasibility Guidance
Favorite
(B-015)
(B-015) Harnessing Real-World Clinicogenomics for Non-Small Cell Lung Cancer Drug Development: An Initial Report
Favorite
(B-163)
(B-163) Health Utilities in Unresectable Hepatocellular Carcinoma: Subgroups Analyses in the IMbrave150 Trial
Favorite
(A-191)
(A-191) Healthcare Resource Utilization Disruptions During the COVID-19 Era and Methodological Considerations: A Review
Favorite
(C-055)
(C-055) Herpes Zoster Incidence Rates by Age for United States adults with Comorbid Conditions
Favorite
(B-026)
(B-026) Herpes zoster Infection and Its Association with Myocardial Infarction: Insights from a Nationwide Self-Controlled Case Series Study
Favorite
(A-104)
(A-104) Heterogeneity of treatment effects of glucagon-like peptide-1 receptor agonists (GLP-1 RA's) for weight loss among adults: A systematic review and meta-analysis of randomized trials
Favorite
(A-106)
(A-106) Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1) on Weight Loss: A Retrospective Cohort Study
Favorite
(A-311)
(A-311) High Throughput Screening for GLP-1 RA-Induced Prescribing Cascades among Older Adults with and without Obstructive Sleep Apnea
Favorite
(SLC-025)
(SLC-025) High-Risk Medications in Pediatric Dentistry: Patterns, Outcomes, and Clinical Implications
Favorite
(A-232)
(A-232) High-throughput screening using self-controlled tree-based scan statistics to identify medications potentially associated with hospitalization for severe acute liver injury
Favorite
(B-298)
(B-298) Hormone Therapy and Risk of Psoriasis in Reproductive and Postmenopausal Women: A Target Trial Emulation
Favorite
(A-161)
(A-161) Hospital admissions due to adverse drug reactions and adverse drug events in older adults: A systematic review
Favorite
(SLC-009)
(SLC-009) Hospital Healthcare Resource Utilization and 12-Month Outcomes Following Total Hip Arthroplasty with ACTIS™ Hip System
Favorite
(C-037)
(C-037) Hospitalization Risk in Persons with and without HIV Initiating Metformin for Type 2 Diabetes
Favorite
(A-225)
(A-225) How are RWE/RWD used in pharmacovigilance for the development of oncologic products in early stages?
Favorite
(B-097)
(B-097) How should we estimate the prevalence of drug use, including polypharmacy?
Favorite
(A-231)
(A-231) β-Blockers and Risk of Neuropsychiatric Adverse Events: An Active-Comparator Restricted Disproportionality on the FAERS
Favorite
(C-157)
(C-157) β-Blockers and Risk of Neuropsychiatric Disorders: A Systematic Review and Meta-analysis.
Favorite
I
(B-242)
(B-242) Identification of Infant Congenital Malformations in a Large US Insurance Claims Database
Favorite
(B-244)
(B-244) Identification of Neonatal Jaundice from Automated Electronic Health Record Data
Favorite
(B-270)
(B-270) Identification of termination of pregnancy due to fetal anomaly (TOPFA) in German claims data
Favorite
(A-026)
(A-026) Identifying opportunities and challenges in the use of real-world data to support the ongoing benefit-risk evaluation of new treatments for Alzheimer’s Disease
Favorite
(C-133)
(C-133) Identifying physician beliefs associated with higher concordance with risk assessment model treatment recommendations for the prevention of venous thromboembolism in an inpatient setting
Favorite
(A-256)
(A-256) Identifying Potential Drug Triggers for Bullous Pemphigoid: A Disproportionality Analysis of the FDA Adverse Event Reporting System and Review of Case Reports
Favorite
(SLB-038)
(SLB-038) Identifying potential drug-drug interaction of concomitant use of methylphenidate and atypical antipsychotics using Korea Adverse Event Reporting System Database
Favorite
(C-004)
(C-004) Identifying Predictive Algorithms for Peri or Post Menopause Symptom Clusters Using Real-World Data (RWD)
Favorite
(C-213)
(C-213) Immune related kidney toxicity, management, and outcomes in ICI treated patients with advanced or metastatic cancers
Favorite
(C-212)
(C-212) Immune related liver toxicity, management, and outcomes in ICI treated patients with advanced or metastatic cancers
Favorite
(C-211)
(C-211) Immune-mediated adverse events in patients with high-risk melanoma receiving immune checkpoint inhibitors in adjuvant and first-line treatment settings: a real-world analysis
Favorite
(SLB-018)
(SLB-018) Immune-related Adverse Events (irAEs) associated with Immune Checkpoint Inhibitor (ICI) Therapy in Bladder Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Favorite
(B-147)
(B-147) Impact analysis of the recent policy interventions for regional polypharmacy reduction in Japan with high older population: A nationwide serial cross-sectional study (April 2020-March 2023)
Favorite
(C-240)
(C-240) Impact and Assessment of Medication Therapy Management Services on Oral Anticoagulants: A Patient-Centric Based Approach
Favorite
(A-115)
(A-115) Impact of 5-Alpha Reductase Inhibitors (5-ARIs) in Prostate Cancer Risk Reduction in Patients with Negative Prostate Biopsy: A Systematic Review and Meta-Analysis.
Favorite
(B-068)
(B-068) Impact of andexanet alfa introduction on mortality and thromboembolic events, before and after Tuscan guidelines, in patients treated with rivaroxaban or apixaban with major bleeding
Favorite
(B-133)
(B-133) Impact of Antibiotic Shortages on Antibiotic Utilisation in the Community: A Cross-National Comparison
Favorite
(B-047)
(B-047) Impact of Colorectal Cancer Diagnosis on Long-Term Type II Diabetes Treatment: A Longitudinal Study
Favorite
(C-057)
(C-057) Impact of cumulative non-pharmacological interventions on the incidence of acute and chronic conditions before and after the COVID-19 pandemic in Europe and the United States
Favorite
(C-152)
(C-152) Impact of design choices that deviate from a target trial emulation. An application to the estimation of the effect of anticholinergic properties of antidepressants on the incidence of dementia
Favorite
(SLC-008)
(SLC-008) Impact of Frailty on Risk of Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Associated with SGLT2 Inhibitors Compared to DPP-4 Inhibitors and GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
Favorite
(B-001)
(B-001) Impact of gabapentinoids use on healthcare utilization and expenditure among female breast cancer survivors in the United States: A propensity-score matched cohort study
Favorite
(A-125)
(A-125) Impact of GLP-1 Receptor Agonists versus DPP-4 Inhibitors and SGLT-2 Inhibitors on Asthma Exacerbations Among Individuals with Asthma and Type 2 Diabetes: A Target Trial Emulation Study
Favorite
(B-081)
(B-081) Impact of Hospital Market Concentration on Spatial Accessibility and Inequality of Antidepressants Before and After Volume-Based Procurement in China
Favorite
(SLB-048)
(SLB-048) Impact of Hurricanes and Related Extreme Weather Events on Health Outcomes: A Scoping Review
Favorite
(A-135)
(A-135) Impact of Immune-Modulating Treatment on Progression from Mild Cognitive Impairment to Alzheimer’s Disease: A US Administrative Healthcare Claims Cohort Study
Favorite
(B-062)
(B-062) Impact of Medicaid Mandatory Medication-Assisted Treatment (MAT) Benefit on Opioid Use Disorder Treatment Utilization, 2018-2022
Favorite
(A-082)
(A-082) Impact of New Antidiabetic Medications on Weight Loss in People with HIV
Favorite
(B-175)
(B-175) Impact of Pharmaceutical Care on the Quality-Adjusted Life Years in Diabetic Foot Ulcer Patients - A Randomized Controlled Trial
Favorite
(B-054)
(B-054) Impact of Pharmacist-Led Medication Therapy Management on Type 2 Diabetes Mellitus in Outpatient Settings: A Systematic Review and Meta-Analysis
Favorite
(B-181)
(B-181) Impact of Serum Creatinine Trajectories Associated with Drug-Related Acute Kidney Injury and Major Adverse Kidney Events in Critically Ill Patients
Favorite
(B-186)
(B-186) Impact of social determinants of health on receipt of guideline-concordant infection prophylaxis among Medicare beneficiaries with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Favorite
(C-143)
(C-143) Impact of study design specifications on effect size heterogeneity of myocarditis risk following COVID-19 vaccination: A systematic review, meta-analysis and meta-regression
Favorite
(B-064)
(B-064) Impact of supply chain disruptions and drug shortages on drug utilization: a scoping review
Favorite
(C-224)
(C-224) Impact of Systemic Corticosteroid Use on Survival Outcomes in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Cohort Study
Favorite
(B-066)
(B-066) Impact of the antibiotics management policy and the COVID-19 pandemic on antimicrobial usage in Japan: A nationwide serial cross-sectional study
Favorite
(B-234)
(B-234) Impact of Three Antimalarial Therapies on Renal Function in Nigerian Children with Uncomplicated Plasmodium Falciparum Infection
Favorite
(A-108)
(A-108) Impact of Treatment Sequencing, and Age on Survival in Metastatic Castration-Resistant Prostate Cancer: A National Health Insurance Database Study
Favorite
(SLB-046)
(SLB-046) Impacts of Extreme Temperature Events on Intraoperative Hypotension: A Multicenter Cohort Study of 276,515 Patients
Favorite
(B-056)
(B-056) Implementation and Evaluation of Deprescribing Among Patients with Polypharmacy in Tertiary Care Hospital
Favorite
(SLC-037)
(SLC-037) Implementing and Validating an Algorithm for Identifying ATTR-CM patients in the PHARMO Data Network
Favorite
(C-207)
(C-207) Implementing robust machine learning pipelines with real-world data: identifying predictors of immune mediated adverse events among patients with advanced melanoma treated with immune checkpoint inhibitors
Favorite
(SLB-024)
(SLB-024) Improved Survival Outcomes in Cancer Patients with Autoimmune Skin Diseases Receiving Immune Checkpoint Inhibitors: A Nationwide Cohort Study
Favorite
(B-153)
(B-153) Improving Quality-of-Care and Preventing Iatrogenesis for a Healthy Ageing – A Survey on Portuguese Healthcare Professionals
Favorite
(SLC-023)
(SLC-023) In utero exposure to mRNA COVID-19 vaccines during the first trimester of pregnancy and risk of congenital anomalies: a national cohort study
Favorite
(B-020)
(B-020) Incidence and Risk Factors of chemotherapy-induced Nephrotoxicity in Cancer Patients with Proper Hydration and Dose Adjustments: A Prospective Hospital-based Study
Favorite
(C-056)
(C-056) Incidence and Severity of Human Metapneumovirus Infection in Adult Populations: A Literature Review
Favorite
(B-027)
(B-027) Incidence of cardiac events in patients with moderate to severe COPD: a retrospective analysis of US claims data
Favorite
(C-217)
(C-217) Incidence of Cataract Among Patients Exposed to FGFR Inhibitors in the Real-World
Favorite
(A-341)
(A-341) Incidence of herpes zoster and vaccination rates in VA long-stay nursing home residents
Favorite
(A-348)
(A-348) Incidence of human metapneumovirus among older adults in 10 high-income countries: a systematic literature review, meta-analysis, and modeling study
Favorite
(B-287)
(B-287) Incidence of Intraocular Inflammation Following Faricimab Treatment: A Real-World Evidence
Favorite
(A-252)
(A-252) Incidence of Outcomes Relevant to Vaccine Safety Monitoring in a General Population, After Influenza Vaccination, and After Respiratory Infections in US Claims Data from August 1, 2022 to July 31, 2023
Favorite
(B-239)
(B-239) Incidence of post-partum hemorrhage and amount of blood loss in the Netherlands
Favorite
(C-222)
(C-222) Incidence of second primary T-cell non-Hodgkin lymphoma among multiple myeloma patients: evidence from real-world data
Favorite
(B-284)
(B-284) Incidence of serious infections in patients with moderate to severe COPD: a retrospective analysis of US claims data
Favorite
(C-239)
(C-239) Incidence of Severe Uterine Bleeding Following Exposure to Non-Vitamin K Antagonist Oral Anticoagulants in South Korea
Favorite
(A-333)
(A-333) Incidence Rates of Safety Events of Interest in a Post-Approval Study of Pfizer-BioNTech Original Monovalent COVID-19 Vaccine in the United States: Primary Series Analysis
Favorite
(A-334)
(A-334) Incidence rates of safety outcomes in a post-approval study of the Pfizer-BioNTech monovalent COVID-19 vaccine in the United States, booster dose analysis
Favorite
(C-036)
(C-036) Incidence Rates of Suicidality Related Events in Patients with Specific Chronic Skin Conditions
Favorite
(B-010)
(B-010) Incidence Trends and Characterisation of Lung Cancer: a Multinational European Cohort Study
Favorite
(C-203)
(C-203) Incorporation of Tokenized Real-World Data into a Phase 4 Vaccine Effectiveness Study: Assessment of Feasibility and Utility
Favorite
(SLA-004)
(SLA-004) Increased Continuity of Oral Contraceptive Therapy following Implementation of Extended Days’ Supply Coverage Mandates in the United States
Favorite
(B-141)
(B-141) Increased Incidence of Parkinson's Disease Associated with Antiseizure Medication Use
Favorite
(A-134)
(A-134) Increased Risk of Clinical Gallstone Disease in New-Users of Calcium Channel Blockers
Favorite
(SLB-047)
(SLB-047) Increased Risk of Hospitalization in Patients with Atrial Fibrillation Exposed to High Particulate Matter
Favorite
(A-045)
(A-045) Indication-Specific Market Share Dynamics of Biosimilars and Originators: A Focus on the TNF-α Inhibitor Market in South Korea
Favorite
(B-187)
(B-187) Inequities in the Use of Orally-administered Antimyeloma Therapies Granted Accelerated Approval
Favorite
(SLA-052)
(SLA-052) Infection-Related Hospitalization After CAR-T Cell Therapy in Commercially Insured Patients with Hematologic Malignancies
Favorite
(B-117)
(B-117) Initial opioid prescriptions for non-cancer patients in Yinzhou China: a retrospective, observational study based on regional medical data during 2011-2023
Favorite
(B-198)
(B-198) Initial-treatment Estimates as Negative Controls for Baseline Confounding Under Low Treatment Persistence: a Real-World Application to Opioids and Diverticulitis
Favorite
(B-130)
(B-130) Initiation of anticoagulants during the COVID-19 pandemic in Sweden: an interrupted time series analysis
Favorite
(SLA-070)
(SLA-070) Innovative use of Generative Artificial Intelligence Copilot to extract data for systematic literature reviews
Favorite
(B-022)
(B-022) Integrated Multi-Setting Real-World Data to Advance Bladder Cancer Evidence Generation
Favorite
(C-154)
(C-154) Integrating Mixed Methods and Actigraphy to Advance Understanding of Adverse Events in Metastatic Breast Cancer: A Multi-Country Study
Favorite
(B-213)
(B-213) Integrating the Patient Perspective Within Real-World Evidence: A Case Study Linking Routinely Collected Patient-Reported Outcomes and Electronic Health Records from Mass General Brigham Healthcare System
Favorite
(SLA-033)
(SLA-033) Integration of Two Large Databases for an Observational Cohort Study of Exposure to Galcanezumab during Pregnancy among Women with Migraine
Favorite
(A-194)
(A-194) Intercurrent Events in Estimands: Where RWE meets RCTs
Favorite
(A-175)
(A-175) Interpretable Machine Learning Models: Describing Treatment Patterns of Healthcare Providers Selecting Rheumatoid Arthritis Therapies to Evaluate Treatment Policies
Favorite
(B-052)
(B-052) Intervention Mapping-based Development of a Pharmacist-led Intervention to discontinue Chronic Antidepressant Use
Favorite
(A-074)
(A-074) Interventions for Improving the Uptake of Preventive Medication Treatments for Breast Cancer: A Systematic Review
Favorite
(C-115)
(C-115) Introduction of an open-access national-level U.S. dementia surveillance system
Favorite
(B-220)
(B-220) Inverse probability weighting to adjust for informative censoring when estimating Desirability of Outcome Ranking (DOOR) probabilities
Favorite
(SLB-036)
(SLB-036) Investigating Potential Drug-Drug-Interactions Between Sacubitril/Valsartan and Statins and the Risk of Myotoxicity, Hepatotoxicity or Acute Pancreatitis: A Post-Authorisation Safety Study in 7 European Healthcare Databases
Favorite
(A-317)
(A-317) Investigating the association between glucagon-like peptide 1 receptor agonists and obstructive sleep apnea incidence using United States Medicare data 2007-2019
Favorite
(C-107)
(C-107) Investigating Treatment Pathways for Rheumatoid Arthritis in Adult Patients: Insights from Real-World Data
Favorite
(C-192)
(C-192) Is There a Lack of Dietary Data Collection in Real-World Pediatric Rare Disease Studies? Literature Review and Future Considerations
Favorite
(A-025)
(A-025) Is there an impact of menstrual cycles on chronic diseases outcomes?
Favorite
(A-172)
(A-172) Iterative Causal Survival Forest: A Novel Subgrouping Algorithm for Survival Data Allowing for Censoring
Favorite
J
(A-043)
(A-043) Janus Kinase Inhibitors with the Risk of Hepatic and Renal Risks: a Nationwide Cohort Study with Active Comparator Design
Favorite
K
(C-139)
(C-139) Knotless Tissue Control Devices For Robotically-Assisted Hand-Sewn Gastrojejunal Anastomosis In Roux-En-Y Gastric Bypass: A Retrospective Comparative Analysis Of Real-World Data
Favorite
L
(B-266)
(B-266) Landscape and Study Design Characteristics of Prospective Observational Cohort Studies on Pregnant Women in China
Favorite
(SLA-066)
(SLA-066) Landscape of Public Health Data Dashboards: Comparison of Key Features for Epidemiology Research
Favorite
(B-274)
(B-274) Leveraging Complementary Study Designs to Enhance Drug Safety Assessment in Pregnancy: Benefits and Limitations
Favorite
(SLB-041)
(SLB-041) Leveraging drugs' therapeutic class to detect three-way drug-drug interactions: a Bayesian approach
Favorite
(B-208)
(B-208) Leveraging multiple-country data sources for a comparative drug safety study: complexities and rewards in pharmacoepidemiology
Favorite
(A-335)
(A-335) Leveraging Real-World Data for Regulatory Commitment: Methodological Considerations in a Post-Approval Safety Study Evaluating the Risk of Atrial Fibrillation (AF) Following Respiratory Syncytial Virus (RSV) Vaccination
Favorite
(C-186)
(C-186) Leveraging Real-World Data Mining to Identify Signals of Attention-Deficit/Hyperactivity Disorder-Associated Adverse Events Using the Korea Adverse Event Reporting System
Favorite
(SLB-059)
(SLB-059) Leveraging Real-World Data to Support Trial Diversity Action Plans – A Fit-for-Purpose Assessment in Waldenström Macroglobulinemia
Favorite
(C-040)
(C-040) Levetiracetam and the Risk of Thrombocytopenia: Active-comparator restricted disproportionality analysis
Favorite
(A-280)
(A-280) Like father, like child: feasibility of linking father and child in CPRD GOLD
Favorite
(A-197)
(A-197) Linkage of clinical trial data to real-world data (RWD) sources: A scoping review
Favorite
(SLC-007)
(SLC-007) Longitudinal Changes in Depressive Symptom Severity with Different Antidepressant Classes among People with HIV
Favorite
(C-149)
(C-149) Longitudinal, Regulatory-Grade Registry Data Can Be Used to Emulate a Target Trial: An Application on Evaluating Treatments for Plaque Psoriasis
Favorite
(A-091)
(A-091) Long-Term Effects of Symptomatic Treatments in Alzheimer's Disease and Related Dementias
Favorite
(C-007)
(C-007) Long-Term Incidence of Psychoactive Medication Prescribing and Psychiatric Condition Occurrence Following ICU Admission with Mechanical Ventilation
Favorite
(A-034)
(A-034) Long-Term Safety of Fingolimod in Multiple Sclerosis: A Scoping Review of Randomized Controlled Trial and Real-World Studies
Favorite
(C-244)
(C-244) Long-Term Safety of Glatiramer Acetate: Evidence from Randomized Trials and Observational Studies in Patients with Multiple Sclerosis
Favorite
(C-043)
(C-043) Lung Function Assessment in Patients with Persistent Asthma: Impact of Disease Severity and Acute Exacerbation Status
Favorite
(C-032)
(C-032) Lyme Disease Reinfections: An analysis of US Health Insurance Claims Data
Favorite
M
(A-180)
(A-180) Machine Learning Methods for Predicting Adverse Drug Events: A Systematic Review
Favorite
(SLA-160)
(SLA-160) Magnitude and Patterns of Potential Diuretic Prescribing Cascades after Calcium Channel Blocker Initiation in Medicare Beneficiaries with and without Congestive Heart Failure
Favorite
(B-196)
(B-196) Making it CLEAR: Using An AI-Assisted Health Literacy Tool to Increase Health Equity in Healthcare and Research
Favorite
(SLA-050)
(SLA-050) Mandated long-term follow-up studies of patients treated with gene and cell therapies approved in the European Union (EU): An analysis of commonalities and variations
Favorite
(SLC-045)
(SLC-045) Mapping the Overall Safety Profile of Levothyroxine-Related Adverse Events: a Disproportionality Analysis on Individual Case Safety Reports Collected by the FAERS
Favorite
(A-287)
(A-287) Maternal Minoxidil Exposure and Infantile Hypertrichosis: A Global Pharmacovigilance Perspective on Dermatological Implications
Favorite
(B-128)
(B-128) Medical Cannabis Use in Association with Drugs Associated with Risks of Interaction with Cannabinoids: A Longitudinal Cohort Study
Favorite
(A-230)
(A-230) Medication Errors in Breast Cancer Treatment and Pharmacist-Led Interventions at the largest referral hospital in Kenya.
Favorite
(A-255)
(A-255) Medication Use Evaluations for Medication Safety Profile and Risk Minimization Measures Assessment: a National Multicenter Study
Favorite
(B-278)
(B-278) Medication use in the pre-conceptional, pregnancy and post-pregnancy periods, with emphasis on drugs for chronic conditions. Data of the PregVal cohort, Spain (2009- 2021).
Favorite
(A-131)
(A-131) Medications with anti-inflammatory mechanisms and risk of non-small cell lung cancer (NSCLC): A population-based case-control study in the US using SEER-Medicare data
Favorite
(SLA-014)
(SLA-014) Metformin Use and Risk of Depression in Patients with Diabetes
Favorite
(C-215)
(C-215) Methodological Approaches to Capture Real-World Adverse Events (AEs) of first-line (1L) Systemic Treatments in Electronic Health Records (EHRs) in a cohort of Patients With Locally Advanced/Metastatic Urothelial Cancer (la/mUC)
Favorite
(B-202)
(B-202) Methodological Approaches to Minimizing Immeasurable Time Bias using Marginal Structural Models
Favorite
(B-206)
(B-206) Methodological Considerations about Policy Impact on Studies of Pregnancy Registries and Maternal/Infant Outcomes
Favorite
(C-194)
(C-194) Methodology and Framework for Estimating the Burden of Rare Diseases Using Regional Healthcare Data
Favorite
(A-354)
(A-354) Methods for Estimating Background Rates of Obstetric and Adverse Events of Special Interest During Pregnancy: A Multi-Site Analysis of Over 3 Million Annual Births
Favorite
(B-305)
(B-305) Methotrexate Safety Monitoring in Patients with Rheumatoid Arthritis
Favorite
(C-153)
(C-153) Mind the Gap: a literature review to assess definitions of treatment discontinuation in oncology studies
Favorite
(C-111)
(C-111) Minimizing racial algorithmic bias when predicting electronic health record data completeness
Favorite
(A-242)
(A-242) Minoxidil-Induced Ocular Disorders: A Global Pharmacovigilance Analysis
Favorite
(B-087)
(B-087) Missed Opportunities for Patient Recruitment in Clinical Trials for Rare Cancers
Favorite
(A-275)
(A-275) Monitoring Incidence of Acute Pancreatitis Following COVID-19 Vaccination compared with Background Incidence in Korea
Favorite
(B-101)
(B-101) Monitoring pediatric prescribing of baricitinib in the United Kingdom during a period prior to approval for use in patients < 18 years of age
Favorite
(A-332)
(A-332) Monitoring safety of Moderna COVID-19 vaccines in pregnancy: a multi-database study in Denmark, Norway, Spain and the United Kingdom. A regulator-mandated postauthorisation safety study in the VAC4EU network (EUPAS44450).
Favorite
(B-272)
(B-272) Mortality and Cancer in Offspring of Mothers with Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) during Pregnancy: A Nationwide Cohort Study
Favorite
(SLB-045)
(SLB-045) Mortality associated to concomitant exposure to corticosteroids and fine particulate matter: an exploratory study in older adults in Rome, Italy
Favorite
(SLA-164)
(SLA-164) Mortality in Patients With Parkinson’s Disease Psychosis Using Pimavanserin Versus Other Antipsychotics
Favorite
(B-156)
(B-156) Motor Vehicle Crash Risk in Older Adults with Alzheimer’s Disease After Acetylcholinesterase Inhibitor Initiation: A Sequential Target Trial Emulation
Favorite
(SLA-163)
(SLA-163) Multidomain frailty index from routine health data and medication use in older patients with and without dementia in Australian hospitals
Favorite
(C-125)
(C-125) Multimorbidity profile and the risk of major cardiovascular events in new antipsychotic users: a time-to-event prediction study using explainable machine learning
Favorite
(SLB-015)
(SLB-015) Multiple Sclerosis Disease-Modifying Therapies and Human Papillomavirus-Related conditions: a disproportionality analysis from the WHO Vigibase
Favorite
(C-175)
(C-175) Myelofibrosis Patients Treated with Momelotinib vs. Best Available Therapy: Evaluating the Use of External Comparator Patients from the Optum Electronic Health Records Database.
Favorite
N
(C-080)
(C-080) Naloxone Prescribing Trends Among Regions and Providers of the United States: Analysis of Medicare Part D Prescriber Data 2013-2022
Favorite
(B-205)
(B-205) Narrative and Analytical Methods to Assess Bias and Pool Results of Studies Associated with Fall-Related Injuries
Favorite
(C-142)
(C-142) National Surveys in Health Outcomes, Pharmacoepidemiology, and Pharmacy Practice Research
Favorite
(B-086)
(B-086) Nervous System Medication Dispensing Patterns Following Teleconsultations in France from January 2021 to June 2023: A Repeated Cross-sectional Study Using the National Health Data System
Favorite
(SLA-056)
(SLA-056) Neurological Adverse Events Associated with Valbenazine in Tardive Dyskinesia: A Meta-Analysis of Randomized Controlled Trials and FAERS Based Disproportionality Analysis
Favorite
(SLB-065)
(SLB-065) New FDA Guidance On Sex Differences In Post-Marketing Studies: How Much Further Do We Need To Go?
Favorite
(A-284)
(A-284) Nicotine Replacement Therapy in Pregnancy: A Systematic Review, Meta-Analysis, and Network Meta-Analysis of Maternal-Neonatal Outcomes and Smoking Cessation
Favorite
(C-145)
(C-145) No Claim Left Behind: Viability of Assessing Early Real-World Vaccine Effectiveness in Open and Closed Administrative Healthcare Claims
Favorite
(C-234)
(C-234) Nonacute Opioid Use and Cardiovascular Risk in Peri- and Post- Menopausal Women: An Observational Cohort Study
Favorite
(B-295)
(B-295) NSAIDs and Gastrointestinal Bleeding: A Comprehensive Meta-Analysis of Individual Drug Risks
Favorite
(C-156)
(C-156) Nuances of Risk Window Selection for Evaluation of Acute Adverse Events
Favorite
O
(C-030)
(C-030) Obesity and obesity-related metabolic factors and incident diverticulitis risk in a US cohort of women
Favorite
(C-058)
(C-058) Obesity and Ventilator-Associated Pneumonia: Results from Electronic Health Record
Favorite
(A-217)
(A-217) Observed rate of safety outcomes, vaccinations, and healthcare utilization in elderly persons with Commercial vs Medicare Advantage insurance in a US Claims Database
Favorite
(A-259)
(A-259) Ocular Adverse Effects of Zoledronic Acid: A Case Report of Partial Vision Loss and Literature Review.
Favorite
(B-063)
(B-063) Off-label Use of Glucagon-like Peptide 1 Agonists (GLP-1): Evidence from Medicare Part D
Favorite
(A-218)
(A-218) Onboarding and characterising NHS health data in the HEalth Data Research UK RWE OMOP Network (HERON-UK)
Favorite
(A-294)
(A-294) Ondansetron in the First Trimester of Pregnancy and Risk of Congenital Malformations: a Study using the New Zealand Pregnancy Cohort
Favorite
(A-293)
(A-293) One Problem, Multiple Solutions
Favorite
(A-022)
(A-022) Opening the DOOR for Patient-Centric Benefit-risk Evaluation:Highlights from the CIOMS Benefit-risk Working Group
Favorite
(B-060)
(B-060) Opioid Agonist Treatment Dispensing Trends Between 2018 and 2022 Across Six Canadian Provinces
Favorite
(C-053)
(C-053) Opioid Tapering and Functional Status among Older Adults on Long-Term Opioid Therapy Receiving Home Health Care
Favorite
(B-291)
(B-291) Opioid-related Emergency Department Visits: An Interrupted Time Series Analysis of Visits Patterns Pre, and Post COVID-19 Lockdown
Favorite
(A-344)
(A-344) Opportunities and Challenges of Using Brazilian Databases in Vaccine Pregnancy Registry Studies
Favorite
(B-120)
(B-120) Optic Neuritis and Corticosteroid Utilization among Patients with Multiple Sclerosis: An Electronic Medical Records Study
Favorite
(B-089)
(B-089) Optimizing Healthcare Outcomes in Ambulatory Patients through Clinical Pharmacist-Led Services
Favorite
(B-230)
(B-230) Optimizing the Identification and Classification of Non-Small Cell Lung Cancer (NSCLC): Validation and Implementation of a Patient Cohort Algorithm in Claims Databases
Favorite
(B-126)
(B-126) Oral antibiotic use with focus on fluoroquinolones during 2010-2021 in four European countries: Finnish results of the HORIZON-EU project “Real4Reg”
Favorite
(C-084)
(C-084) Oral Anticoagulant Use by Comorbidity in Long-term Care: A Population-based Cross-Sectional Study
Favorite
(C-094)
(C-094) Osteoporosis Pharmacotherapy in people with and without Parkinson’s disease in Finland
Favorite
(C-229)
(C-229) Osteoporosis Treatments and the Risk of Myocardial Infarction in Female Patients
Favorite
(C-109)
(C-109) Out of Site, Out of Mind? How Tokenized Linkage Activates Patient Observations across Multiple Real-World Data Sources - the Komodo Research Dataset Example
Favorite
(C-126)
(C-126) Outcomes of digital health intervention in breast cancer survivors: A scoping review
Favorite
(B-201)
(B-201) Overlap Weighting for Residual Bias Reduction in Target Trial Emulation: an Empirical Example from Re-analysis of Our Published Study
Favorite
(A-233)
(A-233) Overview of Post-Authorization Safety Studies Required by EMA for Products Approved in 2022
Favorite
P
(C-020)
(C-020) Paradox Association between Body Mass Index with Occurrence and Fatality of Venous Thromboembolism in Hospitalized Patients: A National Hospital-Based Analysis
Favorite
(B-276)
(B-276) Paternal Linkage in the PHARMO Data Network: Assessing the Impact of Paternal Drug Exposure on Child Health Outcomes
Favorite
(A-347)
(A-347) Patient and Epidemiological Factors Associated with Respiratory Syncytial Virus (RSV) Testing in Adults Hospitalized with RSV-Like Illness, 2023–2024 Respiratory Season
Favorite
(B-160)
(B-160) Patient and Prescriber-related factors associated with return to daily-dispense methadone: A multilevel cohort study
Favorite
(A-031)
(A-031) Patient-reported adverse events and subjective severity and impact among patients diagnosed with non-small cell lung cancer (NSCLC), renal cell cancer (RCC), colorectal cancer (CRC), and metastatic melanoma
Favorite
(A-028)
(A-028) Patient-reported outcomes in dermatological medicines: An overview of EU marketing authorizations from 1998 to 2024
Favorite
(A-019)
(A-019) Patients’ and Caregivers’ Understanding of the Serious Risks of Opioid Analgesics and How to Use These Products Safely: A Patient/Caregiver Survey
Favorite
(A-002)
(A-002) Patterns and predictors of adherence to direct acting antivirals treatment among Medicare beneficiaries with chronic hepatitis C.
Favorite
(SLA-006)
(SLA-006) Patterns of endocrine therapy adherence and the risk of breast cancer recurrence
Favorite
(A-158)
(A-158) Patterns of Long-Term Bisphosphonate Use and Drug Holiday Among U.S. Medicare Beneficiaries
Favorite
(C-088)
(C-088) Patterns of Opioid Reinitiation: Insights from US National Data (2018-2022)
Favorite
(B-245)
(B-245) Pediatric Acute Bacterial Skin and Soft Tissue Infections: Incidence and Antibiotic Prescriptions
Favorite
(C-110)
(C-110) PEPRVision: A Data Insight Engine for Pharmacoepidemiology
Favorite
(A-176)
(A-176) Performance of Machine Learning Predictions of Overall Survival After Multiple Imputations for Features Based on Absolute Non-Missing Degrees
Favorite
(B-292)
(B-292) Perinatal outcomes after the use of Japanese traditional medicines containing ephedra during pregnancy: the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study
Favorite
(B-075)
(B-075) Persistence of Medical Marijuana Use among Certified Patients in the State of Florida
Favorite
(B-073)
(B-073) Pharmacists' Perspectives on Antibiotic Shortages: Implications for Clinical Practice in Australia
Favorite
(B-124)
(B-124) Pharmacoepidemiological study about the usage of antidepressants in young adults in Greece
Favorite
(B-090)
(B-090) Pharosight: A Shiny-Based Interactive Platform with LLM-Enhanced Analyses and Predictive Modeling for Real-World Prescription Data
Favorite
(C-024)
(C-024) Plasma Vitamin D Status and Its Association with Biochemical, Clinical and Humanistic Outcomes in Diabetic Foot Infection Patients: A Prospective Observational Study in a Tertiary Healthcare Facility
Favorite
(B-265)
(B-265) Policy Impact on Pregnancy Registry Participation and Reporting of Maternal/Infant Outcomes
Favorite
(SLB-040)
(SLB-040) Polypharmacy and Drug Combinations Associated with Unintentional Drug Overdose in the United States
Favorite
(C-184)
(C-184) Post-approval pregnancy safety evidence for signal identification: Comparison of preliminary results from two methodological approaches for high-efficacy drugs contraindicated during pregnancy
Favorite
(SLA-049)
(SLA-049) Post-approval Real-world Studies of RNA therapies in the EU: What Can We Learn from Study Characteristics?
Favorite
(A-313)
(A-313) Post-authorization Safety Study to Assess the Risk of Diabetic Ketoacidosis among Type 2 Diabetes Mellitus Patients Treated with Ertugliflozin Compared to Patients Treated with Other Antihyperglycemic Agents
Favorite
(A-271)
(A-271) Postmarketing Requirements for Accelerated Approvals: An Analysis of Status, Therapeutic Areas, and Regulatory Designations
Favorite
(A-355)
(A-355) Post-marketing safety surveillance for bivalent human papillomavirus vaccine in a regional healthcare database in China
Favorite
(C-120)
(C-120) Postpartum Depression and Comorbidities Among Women Participating in Smartphone-Delivered Digital Health Screenings
Favorite
(A-011)
(A-011) Potential Bias in Self-Controlled Case Series Design: Impact of Incident vs. Prevalent Scenarios of Exposure and Outcome
Favorite
(B-110)
(B-110) Potential Drug Interactions among Psychotropic Medications prescribed in Hospitalized Patients at a National Hospital in Peru
Favorite
(A-184)
(A-184) Potential for Extreme Bias Due to Outcome Misclassification in Relative Measures of Effect for Rare Time-to-Event Outcomes
Favorite
(SLA-068)
(SLA-068) Potential High-risk Medication Clusters Prior to Unplanned Hospitalization Among Older Adults: A Latent Dirichlet Allocation Approach Using Nationwide Claims Data
Favorite
(C-238)
(C-238) Potential Related Factors Influencing the Occurrence of CVD in Newly Diagnosed ADHD Patients
Favorite
(C-177)
(C-177) Power vs Precision When Estimating Risk Differences Using Observational Data? A Case Study from TARGET-IBD
Favorite
(A-278)
(A-278) Predicting FDA-Mandated Pregnancy Registries for Future Drug Approvals: Insights from the Thermo Fisher Scientific Drug & Trial Intelligence Dashboard
Favorite
(A-154)
(A-154) Predicting Response to Mono and Dual Antidementia Pharmacotherapy Among Nursing Home Residents
Favorite
(SLC-029)
(SLC-029) Predicting the Probability of Spontaneous Patent Ductus Arteriosus Closure to Inform Clinical Treatment Decisions for Preterm Infants
Favorite
(SLB-019)
(SLB-019) Predicting the Risk of Non-Small Cell Lung Cancer through Polygenic Approach: A US Based Study
Favorite
(B-006)
(B-006) Prediction Models for Diagnosis and Prognosis of Leukemia: Systematic Review and Critical Appraisal
Favorite
(SLA-001)
(SLA-001) Predictors of Adherence to Second Generation Direct Acting Anti-viral Agents among Hepatitis C Virus Infected Patients without Cirrhosis
Favorite
(SLB-051)
(SLB-051) Predictors of Genetic Testing Among Patients With Non-Small Cell Lung Cancer Receiving Targeted Therapy
Favorite
(C-054)
(C-054) Predictors of Home Healthcare Admission among Older Adults on Long-Term Opioid Therapy
Favorite
(B-029)
(B-029) Predictors of initiation, adherence, and persistence to guideline-directed medical therapy following heart failure hospitalizations
Favorite
(B-024)
(B-024) Predictors of Skin Melanoma among Adult population and Its Impact on Quality of Life in the U.S.
Favorite
(B-093)
(B-093) Preliminary results from a European post authorization study to assess the safety of Paxlovid among patients with moderate or severe hepatic or renal impairment
Favorite
(B-257)
(B-257) Preliminary Results from a European Post-Authorization Study to Assess the Safety of Paxlovid in Pregnancy
Favorite
(A-285)
(A-285) Prenatal Exposure to Antiseizure Medication and Associated Risks for Obstetrical Complications: A Population-Based Study
Favorite
(A-286)
(A-286) Prenatal Exposure to Antiseizure Medications and Congenital Malformation Risk in Offspring
Favorite
(SLC-032)
(SLC-032) Prenatal Exposure to Antiseizure Medications and Risk of ADHD in Children
Favorite
(A-140)
(A-140) Prescribing Cascades Potentially Associated with Harms in Long-term Care: A Prescription Sequence Symmetry Analysis
Favorite
(B-072)
(B-072) Prescribing pattern of medicines at orthopedics outpatient department of a tertiary care hospital
Favorite
(C-100)
(C-100) Prescribing Patterns and Lipid Control Outcomes of PCSK9 Inhibitors in the Greater Bay Area of China
Favorite
(A-142)
(A-142) Prescribing Patterns, Polypharmacy, and Drug-Drug Interactions among People Living with HIV in Australia: Insights using National Medication Dispensing Data
Favorite
(A-156)
(A-156) Prescription and Non-Prescription Medication Use Before and After a Herpes Zoster Diagnosis Among Nursing Home Residents in the United States
Favorite
(C-059)
(C-059) PRESIENTE: A Community-Based Prospective Cohort Study of Respiratory and Gastrointestinal Illness in Peru
Favorite
(A-128)
(A-128) Prevalence And Factors of Erythropoietin Hyporesponsiveness in Chronic Kidney Disease Patients Undergoing Hemodialysis At A Public Sector Tertiary Care Teaching Hospital in Kerala: A Cross-Sectional Study
Favorite
(C-033)
(C-033) Prevalence and Incidence of Cutaneous Lupus Erythematosus: A Systematic Literature Review
Favorite
(SLA-161)
(SLA-161) Prevalence and Mortality of HIV-Associated Neurocognitive Disorder (HAND) in Older Medicare Beneficiaries
Favorite
(A-137)
(A-137) Prevalence and prescribing patterns of stress ulcer prophylaxis pharmacotherapy in China: A multi-center, prospective study
Favorite
(B-241)
(B-241) Prevalence of Adolescent Drug Overdose by Drug Involvement and Intent in U.S. Medicaid, 2016-2020
Favorite
(B-019)
(B-019) Prevalence of Chronic Myeloid Leukemia in the European Union
Favorite
(C-197)
(C-197) Prevalence of congenital and acquired generalized lipodystrophy in the EU
Favorite
(A-130)
(A-130) Prevalence of Drug-Gene Interactions Following Acute Myocardial Infarction: An Observational Study Using Data From the UK Biobank
Favorite
(C-128)
(C-128) Prevalence of Key Confounding Covariates in a Commercial Electronic Health Record Platform
Favorite
(B-173)
(B-173) Prevalence of Symptoms among Self-Reported Interstitial Cystitis Patients: A Longitudinal Study Leveraging an Integrated Database
Favorite
(A-049)
(A-049) Prevalence Predictive Modelling of HER2 status in Non-Small Cell Lung Cancer in large multicenter data using machine learning approach and application to SEER: A pilot test
Favorite
(C-144)
(C-144) Prevalent New User Design: Outcome Heterogeneity Based on Different Lengths of Time-Based Exposure Sets
Favorite
(A-162)
(A-162) Prospective Validation of the Adverse Drug Reactions in an Ageing Population Risk Prediction (ADAPTiP) tool and Comparison with Previously Described Risk Prediction Tools: Study Protocol
Favorite
(B-127)
(B-127) Proton pump inhibitor use in infants younger than one year of age: Nationwide Cohort Study Based on the French EPI-MERES Register
Favorite
(C-034)
(C-034) Psychological effects of preterm birth on mothers: A scoping review
Favorite
(A-157)
(A-157) Psychotropic medication prescribing among older adults before and after dementia diagnosis: a retrospective study in Yinzhou, China
Favorite
(C-078)
(C-078) Psychotropic Medication Use among Youth with Schizophrenia in Medicaid Foster Care Program
Favorite
(B-297)
(B-297) Public Reporting of U.S. Food and Drug Administration Post-Marketing Requirement and Commitment (PMR/PMCs) on Drug Safety
Favorite
Q
(C-219)
(C-219) Quality Evaluation of Previous Studies on Glucocorticoid Use and Risk of Site-Specific Cancers: A Systematic Review
Favorite
(B-037)
(B-037) Quantifying Risk in Patients Diagnosed with Pulmonary Embolism Using Electronic Health Record Data with Truveta
Favorite
(C-170)
(C-170) Quantifying the Effect of Treatment Switch: An Illustration with the Prevalent New User Design
Favorite
R
(C-070)
(C-070) Racial and Ethnic Differences in Initiation and Continuation of Treatment Among Medicare Beneficiaries with Opioid Use Disorder from 2010-2019
Favorite
(B-192)
(B-192) Racial and Ethnic Representation in U.S. Based Developmental and Epileptic Encephalopathy Clinical Trials: A Retrospective Analysis
Favorite
(SLB-061)
(SLB-061) Racial Disparity in Cardiovascular Outcomes among Older Women with Breast Cancer receiving Anthracycline
Favorite
(B-132)
(B-132) Raloxifene Use Over Time Among U.S. Medicare Beneficiaries
Favorite
(B-207)
(B-207) Random Patient Selection in Retrospective Chart Review Studies: Cases, Considerations and Insights
Favorite
(SLC-039)
(SLC-039) Rare Findings: Characterizing External Control Arm Studies Assessed by FDA for Drugs and Biologics in Rare Disease
Favorite
(C-019)
(C-019) Rate of Bowel Resection Surgeries among Children with Inflammatory Bowel Disease
Favorite
(SLB-056)
(SLB-056) Real-World Consequences of Drug-Gene Interactions in a National Healthcare System
Favorite
(B-195)
(B-195) Real-World Data Considerations to Generate Estimates of Race and Ethnicity Distributions for Clinical Trial Diversity Plans
Favorite
(A-211)
(A-211) Real-World Data for Evidence Generation Supporting FDA Approvals for Labeling Extension of Drugs and Biologics
Favorite
(B-017)
(B-017) Real-World Data Survival Patterns in Glioblastoma Patients
Favorite
(A-080)
(A-080) Real-world Effectiveness of GLP-1RA for New-Onset Pan Cancer Outcomes: A Debiased Target Trial Emulation Study on Penn EHR study
Favorite
(A-083)
(A-083) Real-world Effectiveness of Interleukin-6 Receptor Inhibitors Compared to Methotrexate in Steroid-refractory Frail Patients with Polymyalgia Rheumatica
Favorite
(A-119)
(A-119) Real-World Effectiveness of Low-Dose Nivolumab Plus Triple Metronomic Chemotherapy in Recurrent/Metastatic HNSCC: A Pragmatic Approach for Resource-Limited Settings
Favorite
(SLC-046)
(SLC-046) Real-World Effectiveness of Osteoporosis Medications in Reducing Fracture Rates Among Men
Favorite
(A-121)
(A-121) Real-World Effectiveness of Ravulizumab in Adults With aHUS who Switched to Ravulizumab Within 3 Months of Eculizumab Treatment (aHUS IMPACT)
Favorite
(C-243)
(C-243) Real-World Evidence of the Impact of Voxelotor on Care Utilization for Patients With Sickle Cell Disease
Favorite
(C-050)
(C-050) Real-world Observational Study of Patients with Potential Non-Idiopathic Progressive Pulmonary Fibrosis and Risk Factors of Progression
Favorite
(C-206)
(C-206) Real-World Prospective Data Assessing the Long-Term Safety of Abrocitinib Treatment in Adults with Moderate to Severe Atopic Dermatitis (AD): Over Two years of Experience from the CorEvitas AD Registry
Favorite
(B-168)
(B-168) Real-world treatment patterns and clinical outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) who received a third line treatment
Favorite
(B-122)
(B-122) Real-World Trends in Prenatal Antirheumatic Drug Utilization in Ontario, Canada: A Cross-Sectional Time Series Analysis
Favorite
(SLB-035)
(SLB-035) Real-World Use of Accelerated Approval Oncology Drugs That Are Subsequently Withdrawn in the United States
Favorite
(B-119)
(B-119) Real-World Utilization Patterns and Adherence to Subcutaneous and Oral Semaglutide in Adults with Type 2 Diabetes Treated in UK Primary Care
Favorite
(A-173)
(A-173) Recalculating Propensity Score or Not for Subgroup Analysis in Propensity Score Matching and Inverse Probability of Treatment Weighting: A Monte Carlo Simulation Study
Favorite
(A-139)
(A-139) Recurrent Urinary Tract Infections and Long-Term Antibiotic Use During Pregnancy in Publicly and Commercially Insured US Populations
Favorite
(C-008)
(C-008) Regional and Socioeconomic Disparities in the Lifetime Risks of Stroke and Its Risk Factors: A Comprehensive Analysis from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
Favorite
(A-336)
(A-336) Regional differences in COVID-19 vaccine uptake and their determinants among Swedish older adults
Favorite
(A-234)
(A-234) Regional Differences in Tramadol Safety Reports: A Global Pharmacovigilance Analysis
Favorite
(B-065)
(B-065) Regional Impact of the COVID-19 Pandemic on Polypharmacy Reduction Policies in Japan: A Nationwide Serial Cross-Sectional Study
Favorite
(A-276)
(A-276) Regional trends of opioid epidemic using safety signal of drug misuse and dependence: a disproportionality analysis using Vigibase
Favorite
(A-047)
(A-047) Regulatory Flexibility in Drug Approval: A Comparative Analysis of U.S. Accelerated Approval and China’s Imported Drug Approval
Favorite
(SLC-019)
(SLC-019) Relapse risk after antipsychotic discontinuation during pregnancy in women with bipolar and psychotic disorder: A propensity-score matched cohort study
Favorite
(A-159)
(A-159) Relationship between sociodemographic factors and discontinuation of high-risk long-term medication in US older adults
Favorite
(SLC-041)
(SLC-041) Remdesivir and Renal Outcomes in Hospitalized COVID-19 Patients Without Severe Renal Impairment: A Retrospective Cohort Study
Favorite
(A-032)
(A-032) REMS Registries: The Role They Play & How They Operate
Favorite
(A-301)
(A-301) Replication of the Association Between Anti-TNF Exposure During Pregnancy and Maternal and Infant Outcomes in the Dorsata Ob-GYN EMR data set and Linked Infant Data
Favorite
(B-148)
(B-148) REpositioning of Medications IN Dementia (REMIND): Evaluating fitness for purpose of the SNDS French nationwide claims database
Favorite
(B-189)
(B-189) Representativeness of Vulnerable Populations in Randomized Controlled Trials Evaluating the Efficacy and Safety of SGLT-2 Inhibitors: A Systematic Review and Meta-analysis
Favorite
(SLA-035)
(SLA-035) Research and Development Costs for Biologic Products Developed by U.S. Biotechnology Startups, 2017-2023
Favorite
(B-084)
(B-084) Residential Proximity to the Coast and Antidepressant Medication Use: Moderating Effects of Seasonal Variation
Favorite
(C-180)
(C-180) Review of Depression Signal Discovered Following Spontaneous Reports of Injectable Anti Diabetics (Semaglutide and Tirzepatide)
Favorite
(C-150)
(C-150) Review of Post-Authorization Safety Studies Submitted to the HMA-EMA Catalogue of RWD Studies Evaluating Cancer as an Outcome
Favorite
(B-263)
(B-263) Review of Pregnancy and Lactation Use Information for Antiepileptic Medications
Favorite
(C-169)
(C-169) Revisiting Representativeness
Favorite
(SLB-064)
(SLB-064) Risk factors associated with post-COVID-19 condition among 810,851 individuals in Sweden: population-based cohort study
Favorite
(SLC-054)
(SLC-054) Risk factors for myocarditis/pericarditis following mRNA-1273 vaccination: interim analysis of a VAC4EU case-cohort study
Favorite
(B-237)
(B-237) Risk factors for Staphylococcus aureus (S. aureus) and Methicillin-resistant Staphylococcus aureus (MRSA) carriage in children: a case-control study
Favorite
(A-021)
(A-021) Risk Minimization Strategies for Preventing Prenatal Exposure to Teratogenic Medications: Evaluating the Evidence
Favorite
(B-296)
(B-296) Risk of Acute Kidney Injury Associated with Nephrotoxic Burden: A Systematic Review of Observational Studies
Favorite
(C-245)
(C-245) Risk of Acute Kidney Injury with Concurrent Vancomycin and Piperacillin-Tazobactam Treatment in Hospitalized Patients with Community-Acquired Pneumonia Diagnosis
Favorite
(SLB-030)
(SLB-030) Risk of Acute Kidney Injury with Non-vitamin K Antagonist Oral Anticoagulants Use: A Retrospective Cohort Study
Favorite
(A-010)
(A-010) Risk of Acute Pancreatitis Associated with the Use of Dipeptidyl Peptidase-4 Inhibitors: Application of the Trend-in-Trend Design
Favorite
(A-321)
(A-321) Risk of adverse opioid-related outcomes among adult Medicaid enrollees with new long-term prescription opioid use
Favorite
(SLC-049)
(SLC-049) Risk of Atrial Fibrillation After Bivalent COVID-19 Vaccination During the 2022-2023 Season
Favorite
(B-301)
(B-301) Risk of Autoimmune Disease after COVID-19 vaccination: A modified Self-controlled case series study
Favorite
(B-004)
(B-004) Risk of Cancer in Patients with First-Time Seizure: A Population-Based Cohort Study
Favorite
(B-262)
(B-262) Risk of Developmental Delay in Offspring of Patients Exposed to Treatments for Bipolar Disorder During Pregnancy
Favorite
(A-316)
(A-316) Risk of Diabetic Ketoacidosis Across Stages of Chronic Kidney Disease in Patients with Type 1 Diabetes in the U.S. Food and Drug Administration’s Sentinel System
Favorite
(C-183)
(C-183) Risk of gastrointestinal hemorrhage associated with SSRI and SNRI antidepressant products: a review and meta-analysis
Favorite
(A-110)
(A-110) Risk of Hepatocellular Carcinoma after Kidney Transplantation in Patients with End-Stage Renal Disease: A Population-based Cohort Study Using Multi-Institutional Electronic Health Records
Favorite
(B-283)
(B-283) Risk of Hyponatremia Associated With the Use of Antidepressants: a Large-Scale Federated Data Analysis of Multiple Institutions Using Common Data Model
Favorite
(A-315)
(A-315) Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors, Sodium Glucose Cotransporter 2 Inhibitors, or Sulfonylurea in the U.S. Food and Drug Administration’s Sentinel System
Favorite
(B-261)
(B-261) Risk of Major Congenital Anomalies in Offspring of Patients Exposed to Treatments for Bipolar Disorder During Pregnancy
Favorite
(B-280)
(B-280) Risk of Newborn Congenital Abnormalities after Exposure to Misoprostol during Pregnancy: A Systematic Review and Meta-Analysis
Favorite
(A-089)
(A-089) Risk of obstructive sleep apnea associated with the use of SGLT2 inhibitors in patients with type 2 diabetes: A nationwide cohort study
Favorite
(A-308)
(A-308) Risk of pre-sarcopenia and SGLT2 inhibitors in young adults with type 2 diabetes: A nationwide cohort study
Favorite
(A-300)
(A-300) Risk of Preterm Birth with Clindamycin vs. Metronidazole in Pregnant Women with Bacterial Vaginosis: A Retrospective Cohort Study
Favorite
(A-296)
(A-296) Risk of Psychiatric Relapse After First-Trimester Antipsychotic Discontinuation in Pregnant Women with Schizophrenia
Favorite
(SLB-020)
(SLB-020) Risk of Secondary Primary Malignancies among Patients with Selected Hematologic Cancers: US population-based analysis of SEER
Favorite
(B-306)
(B-306) Risk of Severe Exacerbation Associated with Gabapentinoid Use in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
Favorite
(B-273)
(B-273) Risk of Severe Infections in Offspring of Mothers with Biopsy-Proven Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) During Pregnancy: A Nationwide Cohort Study
Favorite
(B-282)
(B-282) Risk of upper gastrointestinal (GI) bleeding associated with initiation of oral systemic corticosteroids among patients with and without any pre-existing GI bleed
Favorite
(SLC-053)
(SLC-053) Risk of Venous Thrombosis With Thrombocytopenia Syndrome After Vaccination With AZD1222: A European VAC4EU Post-Authorisation Safety Study
Favorite
(B-238)
(B-238) Risk Prediction Models for Adverse Drug Reactions in Pediatric Patients: A Systematic Review
Favorite
(A-239)
(A-239) Risk-Based Stratification of Pharmacovigilance Data for a Differentiated Approach to Follow-Up
Favorite
(SLA-051)
(SLA-051) Role of the Regulatory Science Center in the Safety Management of Advanced Biological Products in Korea
Favorite
S
(B-248)
(B-248) Sacubitril-valsartan and Risk of Ototoxicity: A Disproportionality Analysis
Favorite
(C-235)
(C-235) Safety and Effectiveness of Anticoagulation in Cancer Patients with Venous Thromboembolism: A Population-based Cohort Study
Favorite
(A-245)
(A-245) Safety and Effectiveness of B/F/TAF for the Treatment of HIV-1 Infection in a Large Cohort in South Korea: A Post-marketing Surveillance Study
Favorite
(B-188)
(B-188) Safety and Effectiveness of Cemiplimab in Combination with Platinum-Doublet Chemotherapy by Demographic Characteristics in First-Line Treatment of Advanced Non-Small Cell Lung Cancer: An Ongoing Real World Evidence Study
Favorite
(C-246)
(C-246) Safety and Utilization of Fezolinetant for Menopause Symptoms
Favorite
(B-250)
(B-250) Safety Assessment on the Risk of Liver Dysfunction by ACE Inhibitors utilizing the MID-NET® in Japan
Favorite
(SLC-052)
(SLC-052) Safety Evaluation of Multiple Vaccination Regimens for the Elderly in Japan: The VENUS Study
Favorite
(A-329)
(A-329) Safety Monitoring of Health Outcomes following Influenza Vaccination during the 2023–2024 Season among U.S. individuals aged 6 months through 64 years
Favorite
(B-308)
(B-308) Safety Monitoring of Mpox Vaccines in Adults Aged 18–64 Years during the 2022 Mpox Outbreak in the U.S.
Favorite
(A-331)
(A-331) Safety Monitoring of Multiple Health Outcomes following 2023–2024 COVID-19 Vaccination among Commercial Health Plan Enrollees Aged 6 Months–64 Years in the United States
Favorite
(A-342)
(A-342) Safety of COVID-19 vaccination among patients with autoimmune diseases in Korea: a population-based self-controlled case series study
Favorite
(B-246)
(B-246) Safety of Immune Checkpoint Inhibitors: A Systematic Review of Disproportionality Analysis Studies
Favorite
(A-260)
(A-260) Safety of Moderna’s Omicron-Containing Bivalent and XBB1.5- containing Monovalent Vaccines: Results from a US Claims Database Cohort Study
Favorite
(SLC-022)
(SLC-022) Safety of Nausea and Vomiting of Pregnancy Treatments: A US MotherToBaby Prospective Cohort Study
Favorite
(C-166)
(C-166) Safety of Transient Oral Corticosteroids Use in Mild-to-Moderate Asthma for Exacerbation Management: Methodological Review and Beyond
Favorite
(A-356)
(A-356) Safety Profile of Vaxzevria® COVID-19 Vaccine in the COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER)
Favorite
(A-241)
(A-241) Safety Reporting of Homeopathic Products: A Preliminary Investigation in the FDA Adverse Event Reporting System (FAERS) Data
Favorite
(A-251)
(A-251) Safety signal monitoring of an anti-COVID-19 drug in the MID-NET® in Japan
Favorite
(A-101)
(A-101) Salient features and related variables with the possibility of initial antidepressant modification: A prospective study in a tertiary-care teaching hospital in India
Favorite
(SLB-025)
(SLB-025) Second Primary Malignancy in Patients with Diffuse Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy and Other Systemic Anti-Cancer Therapy: A Real-World Evidence from a Large US National Claims Database
Favorite
(C-214)
(C-214) Second Primary Malignancy in Patients with Multiple Myeloma Receiving Chimeric Antigen Receptor T-Cell Therapy and Other Systemic Anticancer Therapy: A Comparative Study Using a Real-World Database
Favorite
(A-283)
(A-283) Second-Line Antidiabetic Medications in Early Pregnancy: Do They Increase Miscarriage Risk?
Favorite
(C-161)
(C-161) Self-controlled Methodology and Test Negative Design to Evaluate Waning Effectiveness of COVID-19 and Influenza Vaccination in the Veterans Health Administration
Favorite
(A-290)
(A-290) Self-Reported Intake of Harmful Medications During Pregnancy: Insights from 24 Years of Swedish Data
Favorite
(A-221)
(A-221) Self-Reported Use of Non-FDA Approved Cannabinoid Products among Hospitalized Patients in a Large US Hospital Network
Favorite
(A-310)
(A-310) Serum 25-Hydroxyvitamin D Levels and Risk of Diabetes Complications in Sulfonylurea Users: A Linked Database of Kangbuk Samsung Health Study and Nationwide Claims Data
Favorite
(B-191)
(B-191) Setting diversity goals for clinical trials: Epidemiologic considerations
Favorite
(A-129)
(A-129) Sex differences in the comparative effectiveness of second-line antidiabetic medications at preventing cardiovascular outcomes
Favorite
(SLB-063)
(SLB-063) Sex-Related Differences in the Risk of Rehospitalization among Heart Failure Patients in Korea
Favorite
(B-039)
(B-039) SGLT2 inhibitors and major renal outcomes among Medicare beneficiaries with heart failure
Favorite
(C-002)
(C-002) SGLT2 Inhibitors and Nephrolithiasis Risk in Patients with Type 2 Diabetes: A Cohort Study and Meta-analysis
Favorite
(C-182)
(C-182) Sight-threatening Eye Disorders in Patients Treated with Semaglutide : A Disproportionality Analysis Using the FAERS Database
Favorite
(A-224)
(A-224) Signal Detection of Dementia Associated with Alkylating Agents: Using the World Health Organization Pharmacovigilance Database
Favorite
(SLA-038)
(SLA-038) Single and multiple switches, swap and retransitioning among 28,073 biological drug users with inflammatory bowel disease: results from Italian VALORE distributed database network
Favorite
(C-063)
(C-063) Single-Dose Doxycycline for Lyme Disease Prophylaxis in Children in a Large United States Healthcare Database, 2016-2020
Favorite
(B-030)
(B-030) Social Determinants of Health and Disparities in GLP-1 Therapy Access Among Type 2 Diabetes Patients with Stage 2 CKM: Insights from NHANES Data
Favorite
(A-360)
(A-360) Social Disparities in HPV Vaccination Uptake Among Adolescent Girls in France (2007–2023)
Favorite
(B-256)
(B-256) Sociodemographic Determinants and Inequities in Prenatal Healthcare in the Canadian province of Manitoba: A Population-Based Cohort Study (2010-2022)
Favorite
(SLC-003)
(SLC-003) Sodium-Glucose Co-Transporter-2 Inhibitor Use and Risks of Exacerbation and Pneumonia in Patients with Chronic Obstructive Pulmonary Disease and Diabetes Mellitus: A Population-Based Cohort Study
Favorite
(A-088)
(A-088) Sodium-Glucose Cotransporter-2 Inhibitors and Risk of Autoimmune Rheumatic Diseases: A Population-based Cohort Study
Favorite
(B-170)
(B-170) Spending, Utilization, and Price Trends for Anti-Obesity Medications in US Medicaid Programs: A Comprehensive Analysis from 1999 to 2023
Favorite
(B-078)
(B-078) Stakeholder Analysis of Responses to the FDA’s Discussion Paper on Artificial Intelligence and Machine Learning in Drug and Biological Product Development
Favorite
(SLA-063)
(SLA-063) Standardising Clinical Practice Research Datalink data linked to hospital admissions and cancer registry data in prostate cancer
Favorite
(C-118)
(C-118) Standardization of CLARION study-specific data using a common data model: Experience from multiple sclerosis registries and data sources
Favorite
(A-200)
(A-200) Strengthening inferential studies in the U.S. FDA Sentinel initiative: Results from a methodological demonstration project
Favorite
(SLB-013)
(SLB-013) Structured benefit-risk assessment for isatuximab in transplant-ineligible newly diagnosed multiple myeloma patients
Favorite
(A-312)
(A-312) Study design and comparator choices in evaluating the risk of suicidal ideation and suicidality with semaglutide: A real-world study
Favorite
(A-023)
(A-023) Studying paternal drug exposures and offspring outcomes: feasibility assessment of large European databases
Favorite
(A-189)
(A-189) Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data (RWD): Challenges and Solutions to Avoid Biases that Generate Immortal Time
Favorite
(B-183)
(B-183) Systematic Review: Cost-Benefit Analysis of Rivaroxaban Versus Warfarin Using a Decision Tree Model
Favorite
T
(A-226)
(A-226) Target Fishing and Drug Repurposing for Esophageal Adenocarcinoma: An Integrated Bioinformatic and Pharmacovigilance Approach
Favorite
(B-114)
(B-114) Temporal Trends in Clinical Characteristics and Treatment Patterns of Patients with Both CKD and T2D Initiating a GLP-1 RA and SGLT2i: Findings From a Large Database in the United States, 2014-2023
Favorite
(SLB-062)
(SLB-062) Temporal Trends in Racial Differences in Initiation of Medication for Opioid Use Disorder Among Medicaid Beneficiaries
Favorite
(A-096)
(A-096) The association between angiotensin-converting enzyme inhibitors and the risk of diabetic retinopathy in patients with type 2 diabetes: a population-based real world study
Favorite
(B-279)
(B-279) The association between childhood asthma and frozen versus fresh embryo transfer in assisted reproductive technology: a nationwide retrospective cohort study using target trial emulation framework
Favorite
(B-028)
(B-028) The Association Between Dose and Formulation of Long-term Opioid Therapy and the Risk of Cardiovascular Outcomes in Older Adults
Favorite
(A-178)
(A-178) The association between fibrate use and the risk of diabetic peripheral vascular disease in patients with type 2 diabetes mellitus: A nested case-control study
Favorite
(A-056)
(A-056) The Association Between Long-Term Outdoor Air Pollution Exposure and Inhaler Prescriptions in General Practices in England
Favorite
(A-153)
(A-153) The association between metformin-based regimens and cognitive performance in participants with type2 diabetes in the UK Biobank
Favorite
(SLC-005)
(SLC-005) The Association of Glucagon-Like Peptide-1 Receptor Agonists with Depression, Anxiety, and Alcohol Misuse in Individuals with Type 2 Diabetes Mellitus
Favorite
(SLC-006)
(SLC-006) The Association of Sodium-Glucose Cotransporter-2 Inhibitors with Cancers in Individuals with Type 2 Diabetes Mellitus
Favorite
(C-168)
(C-168) The Big Four: An Enhanced Framework for Drawing Causal Inferences from Observational Data
Favorite
(C-025)
(C-025) The burden of physical and psychological symptoms among patients with asthma in Jordan
Favorite
(A-145)
(A-145) The comparative risk of diagnosed depression among older men with metastatic castration resistant prostate cancer initiating enzalutamide versus abiraterone
Favorite
(SLB-014)
(SLB-014) The Effect of Antibiotics on the Risk of Parkinson’s Disease: A Meta-Analysis of Observational Epidemiological Studies
Favorite
(A-299)
(A-299) The Effect of COVID-19 During Pregnancy on Fetal Outcomes: A Propensity Score Matched Analysis using Mother-Infant Linked Claims Data
Favorite
(A-144)
(A-144) The Effect of Heat on The Heart Failure Exacerbation Caused by Alpha-blockers
Favorite
(A-122)
(A-122) The Effectiveness of HPV Vaccination in Women Younger Than 18 Years Old to Prevent HPV-Related Pre-Cancerous Lesions and Cancers: a UK Population-Based Cohort Study
Favorite
(B-290)
(B-290) The Effectiveness of the Safety Communication for Concurrent Benzodiazepine-Opioid Therapy: A Retrospective Real-World Analysis
Favorite
(A-307)
(A-307) The Effectiveness on Diabetic Retinopathy Between GLP-1 Receptor Agonists and DPP-4 Inhibitors in Taiwan
Favorite
(B-088)
(B-088) The evolving landscape of clinical trials in Peru
Favorite
(B-300)
(B-300) The Impact of Air Pollution on Postoperative Renal Injuries: a multicenter observational cohort study of 268,867 patients
Favorite
(B-227)
(B-227) The Impact of COPD Severity Misclassification on Patients with Different Comorbidities Using a Validated Process: A Nationwide Cohort Study
Favorite
(B-059)
(B-059) The impact of drug shortages in the use of medicines across 52 real-world data sources in 19 countries in Europe and North America
Favorite
(B-218)
(B-218) The Inclusion of Dietary Data in Real-World Gastroenterology Studies: Insights from a Literature Review on Crohn’s Disease
Favorite
(B-076)
(B-076) The Inflation Reduction Act Lowers Out-of-Pocket Costs for Orally-Administered Blood Cancer Therapies
Favorite
(SLA-162)
(SLA-162) The Prevalence of Central Nervous System-Active Polypharmacy in U.S. Nursing Homes During the COVID-19 Visitation Restriction
Favorite
(SLB-044)
(SLB-044) The Relationship between Wildfire Smoke Exposure and Childhood Asthma in California
Favorite
(A-327)
(A-327) The risk of mortality in patients with Multiple Sclerosis treated with alemtuzumab compared to other disease modifying therapies: A cohort study with data from five countries
Favorite
(SLB-011)
(SLB-011) The risk of suicidality with the use of 5-Alpha-Reductase Inhibitors: Real-world evidence utilizing the Food and Drug Administration Adverse Event Reporting System (FAERS)
Favorite
(A-277)
(A-277) The Role of Pharmacovigilance Databases in Identifying Antibiotic Resistance and Inappropriate Use
Favorite
(C-074)
(C-074) The temporal trends of Escherichia coli antimicrobial resistance and antibiotic utilization in Australian Long-Term Care Facilities
Favorite
(B-021)
(B-021) The value of integrating multi-care settings real world data for understanding prostate cancer management
Favorite
(C-193)
(C-193) Therapeutic Horizon in Multiple Myeloma: Emerging Therapies and Future Perspectives
Favorite
(B-277)
(B-277) Thiopurine treatment and intrahepatic cholestasis of pregnancy in pregnancies with systemic lupus erythematosus and inflammatory bowel disease - A Swedish cohort study
Favorite
(C-232)
(C-232) Thrombosis and Bleeding Risk in Patients Receiving NOACs and P-gp Inducers or Inhibitors: A Case-Case-Time-Control for Drug Interactions Assessment
Favorite
(B-036)
(B-036) Timely Disease Surveillance: Can a Large National EHR Network be Used to Estimate National and State Prevalence of Obesity and Type 2 Diabetes?
Favorite
(B-145)
(B-145) Timing of Symptomatic Treatment Discontinuation on Neuropsychiatric and Functional Outcomes in Alzheimer's Disease and Related Dementias
Favorite
(A-192)
(A-192) Title: Fostering Creativity in AI: Insights from a Datathon Tackling HIV Screening Challenges
Favorite
(C-167)
(C-167) Toward exposure-wide and outcome-wide pharmacoepidemiology for generating high-quality real-world evidence
Favorite
(A-212)
(A-212) Towards Accurate Data Linkage: A Comparison of Deterministic, Probabilistic, and Machine Learning Approaches Applications in Multiple Sclerosis
Favorite
(B-224)
(B-224) Towards Optimizing Identification of First Line of Therapy (LOT) for Metastatic Lung, Breast and Colorectal Cancer in Real World Data: A Scoping Review
Favorite
(C-095)
(C-095) Trajectories of Osteoporosis Pharmacotherapy among Older Treatment-Naïve Females
Favorite
(B-174)
(B-174) Transcending barriers to pain care in rural America: a pragmatic comparative effectiveness trial of evidence-based, on-demand, digital behavioral treatments for chronic pain
Favorite
(A-179)
(A-179) Transfer Learning Strategies for Addressing Class Imbalance in Drug Adverse Reaction Prediction: Simulation and Empirical Analysis
Favorite
(C-155)
(C-155) Transforming a Large-Scale Prostate Cancer Outcomes Dataset to the OMOP Common Data Model—Experiences with a Regional Health Record Database in China
Favorite
(A-029)
(A-029) Transparency in the Training, Validation, and Testing of Artificial Intelligence-Based Tools for Real-World Evidence Synthesis
Favorite
(A-105)
(A-105) Transporting the effects of lung cancer screening from the National Lung Screening Trial (NLST) to a nationally representative US screening-eligible population
Favorite
(B-302)
(B-302) Treatment associated serious infection in patients with moderate to severe psoriasis: A cohort study from UK and Ireland
Favorite
(C-103)
(C-103) Treatment of Type 2 Diabetes Among Medicare Beneficiaries With and Without Alzheimer’s Disease: A Retrospective Cohort Study
Favorite
(B-092)
(B-092) Treatment Patterns and Clinical Outcomes Among Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Favorite
(C-093)
(C-093) Treatment patterns in pediatric type 1 diabetes mellitus patients in Taiwan
Favorite
(SLB-034)
(SLB-034) Treatment Patterns in Pediatrics with Attention-Deficit Hyperactivity Disorder (ADHD) in Taiwan
Favorite
(C-072)
(C-072) Treatment Patterns of Immunoglobulin Replacement Therapy Among Patients with Multiple Myeloma in the United States: a Real-World Analysis
Favorite
(B-013)
(B-013) Treatment Patterns on Early-Stage Melanoma: Results from a Multi-site Chart Review
Favorite
(B-240)
(B-240) Treatment-Resistant Depression (TRD) in Children and Adolescents and its Life-Course Determinants
Favorite
(C-099)
(C-099) Trends in Clinical Prescription Patterns and Selection of Anabolic drugs for postmenopausal women with osteoporosis in Taiwan
Favorite
(B-144)
(B-144) Trends in Drug-Drug Interactions Among US Older Adults, 2015-2016 vs. 2021-2023
Favorite
(SLC-017)
(SLC-017) Trends in FDA Comments on the Design, Conduct, and Analysis of Pregnancy Exposure Registries: A Summary of Findings at a Clinical Research Organization (CRO)
Favorite
(C-090)
(C-090) Trends in insulin utilization and SARIMA forecasting: A time-series analysis in Greece (2016–2023) using IQVIA dataset
Favorite
(B-135)
(B-135) Trends in Menopausal Hormone Therapy dispensing in Australia between 2014 and 2023
Favorite
(C-092)
(C-092) Trends in opioid prescribing prior to opioid toxicity inpatient hospitalizations and ED visits in Canada, 2018-2022
Favorite
(C-091)
(C-091) Trends in Outpatient Antibiotic Prescribing in the United States using Real World Data from 2020 to 2024
Favorite
(B-112)
(B-112) Trends in Outpatient Influenza Antiviral Use in US Adults: 2010-2021
Favorite
(C-064)
(C-064) Trends in Polycystic Ovary Syndrome and Its Associated Pharmacological Treatments in the United Kingdom from 1998 to 2023
Favorite
(C-076)
(C-076) Trends in Postpartum Anti-Obesity Medication Use among Commercially Insured Pregnant Women, 2016-2022
Favorite
(C-102)
(C-102) Trends in prescription opioid use for pain in Canada: a population-based repeated cross-sectional study
Favorite
(C-104)
(C-104) Trends in Spironolactone Incidence by Indication among Young Women and Girls in the United States: Quantifying Patterns of On-label and Off-label Prescribing
Favorite
(C-098)
(C-098) Trends in the consumption of psychotropic drugs in France, in children, adolescents and young adults between 2012 and 2023
Favorite
(B-016)
(B-016) Trends in the Incidence of Monoclonal Gammopathy of Undetermined Significance (MGUS) Before and During the COVID-19 Pandemic
Favorite
(C-096)
(C-096) Trends in the Prescription of Central Nervous System Depressants in Patients with Chronic Obstructive Pulmonary Disease in the United Kingdom Primary Care, 2000 – 2022
Favorite
(SLC-034)
(SLC-034) Trends in type 1 diabetes mellitus onset among youth aged 0 to 20 in Korea before and after COVID-19: A nationwide health insurance claims data analysis, 2003-2022
Favorite
(B-233)
(B-233) Trends in Utilization of Chronic Asthma Medications among Publicly Insured Children in the US: 2003 to 2020
Favorite
(C-106)
(C-106) Trends in Utilization, Spending, and Pricing of Janus Kinase (JAK) Inhibitors in the U.S. Medicaid Program (2011-2023)
Favorite
(SLA-007)
(SLA-007) Trends of Antidepressants Use During Pregnancy: a Nationwide Cohort Study
Favorite
(B-046)
(B-046) Trends over time in antidiabetic medication use under age 65 in the United States: impact of obesity treatment
Favorite
(B-131)
(B-131) Trends, Patterns, and Characteristics of Gabapentin Use among Medicare Beneficiaries (2012-2021)
Favorite
(A-258)
(A-258) Trimethoprim-Sulfamethoxazole (TMP-SMX) and Risk of Hemophagocytic Lymphohistiocytosis (HLH): A Literature Review and Disproportionality Analysis Using Individual Safety Case Reports from FAERS
Favorite
(C-187)
(C-187) Turn me on! Turn me off! Sexual Dysfunctions as Adverse Drug Reactions of Antipsychotic Medications
Favorite
(SLA-057)
(SLA-057) Two Decades of ADHD Diagnosis Trends in British Columbia: A Population-Based Study
Favorite
(A-330)
(A-330) Type 1 Diabetes Mellitus in Individuals Receiving COVID-19 Messenger RNA Vaccination
Favorite
U
(B-071)
(B-071) Uncertainty in Pre-approval and Post-approval Clinical Evidence of Drugs Granted Conditional Approval in China
Favorite
(B-109)
(B-109) Understanding Real-World Use of Guideline-directed Medical Therapy in Chronic Health Failure
Favorite
(C-031)
(C-031) Understanding the age-specific risk factors for COVID-19: A machine learning approach
Favorite
(B-247)
(B-247) Understanding the natural history of heart failure by ejection fraction: a systematic review of common comorbidities, readmission rates, and mortality rates
Favorite
(B-007)
(B-007) Updated Trends in incidence, prevalence, and survival in patients with Head and Neck Squamous Cell Carcinoma in the United States
Favorite
(B-045)
(B-045) Uptake and use of biologic medicines in paediatric immune-mediated inflammatory diseases: An Australian population-based study
Favorite
(B-107)
(B-107) Uptake of online pharmacy services among adult patients attending the diabetes clinic at the largest referral hospital in Kenya and the implications on medicines utilisation.
Favorite
(B-043)
(B-043) Use Of Antidiabetic Agents In Type 2 Diabetes Mellitus Patients With Chronic Kidney Disease At A Teaching And Referral Hospital In Western Kenya
Favorite
(B-083)
(B-083) Use of Belatacept and Tacrolimus Among Kidney Transplant Recipients From 2011-2020: Comparing United States Renal Data System (USRDS) and Scientific Registry of Transplant Recipients (SRTR)
Favorite
(A-325)
(A-325) Use of fluoroquinolones and the risk of seizures: a population-based cohort study
Favorite
(B-123)
(B-123) Use of Glucagon-like Peptide 1 Agonists (GLP-1's) Among Individuals Undergoing Bariatric Surgery In The United States: A Retrospective Cohort Study
Favorite
(C-077)
(C-077) Use of Glucagon-Like Peptide-1 Receptor Agonists in the U.S. Food and Drug Administration’s Sentinel System
Favorite
(A-198)
(A-198) Use of International Classification of Functioning, Disability and Health in Randomized Control Trials in Rheumatoid Arthritis: a scoping review
Favorite
(B-035)
(B-035) Use of lipid lowering therapies (LLTs) among adults by type 2 diabetes (T2D) diagnosis, with discordant apolipoprotein B (apoB) and LDL-cholesterol (LDL-C) values using US real-world data
Favorite
(SLA-015)
(SLA-015) Use of Quetiapine vs Risperidone and Risk of Cardiovascular Diseases in Patients with Parkinson’s Disease Psychosis
Favorite
(A-030)
(A-030) Use of Real-World Evidence to Satisfy U.S. FDA Postmarketing Requirements and Commitments
Favorite
(C-113)
(C-113) Use of sodium valproate and other antiseizure drug treatments in England and Wales: quantitative analysis of nationwide linked electronic health records
Favorite
(C-083)
(C-083) Use of Statins for Primary Prevention among Individuals with Chronic Kidney Disease in The United States: A Cross-Sectional, Time-Trend Analysis
Favorite
(C-218)
(C-218) Use of Systemic Glucocorticoids and Risk of Prostate Adenocarcinoma: Evidence From a Danish Population-Based Case-Control Study
Favorite
(B-103)
(B-103) Use of Systemic Oral Fluoroquinolones in France Between 2014 and 2023: A Nationwide Population-Based Study Using The French National Health Data System
Favorite
(A-187)
(A-187) Using a Random Slope Model to Evaluate the Association Between Initial High/Low Opioid Dosage and Kidney Function Change Over One Year Post-Surgical Discharge
Favorite
(A-190)
(A-190) Using causal trees to explore the heterogeneity of effects
Favorite
(A-267)
(A-267) Using Machine Learning to Predict Classification of Causal and Non-causal Pharmacovigilance Cases
Favorite
(C-134)
(C-134) Using Real-World Data and Digital Phenotyping to Identify Candidates for anti-CGRP Migraine Treatment
Favorite
(C-052)
(C-052) Using Real-World Data Landscaping to Address Gaps in Patient Insights: A Real-Use Case Study in Chronic Wound Care
Favorite
(C-160)
(C-160) Using the Potential Outcomes Model to Inform the Design and Interpretation of Causal Studies of the Effectiveness and Safety of Healthcare Interventions: An Interdisciplinary Perspective
Favorite
(A-358)
(A-358) Using Tree-Based Scan Statistics to Monitor Routine Vaccines for Possible Associations with Guillain-Barré Syndrome in the Vaccine Safety Datalink
Favorite
(B-225)
(B-225) Utility of Restricted Mean Duration of Response as an Intermediate Outcome in Advanced Non-small Cell Lung Cancer
Favorite
(C-138)
(C-138) Utilization of a Knotless Tissue Control Device for Robotically-assisted Hand-sewn Gastrojejunal Anastomosis in Roux-en-Y gastric Bypass: A Retrospective Analysis of Real-world Data
Favorite
(A-033)
(A-033) Utilization of erenumab and other prophylactic migraine treatments: a regulator-mandated population-based cohort study in four Nordic countries (EUPAS36014)
Favorite
(C-062)
(C-062) Utilization of hormonal contraceptives during the postpartum period in the FDA Sentinel System
Favorite
(B-096)
(B-096) Utilization of migraine treatments in pregnancy: results of a regulator-mandated population-based study in four Nordic countries (EUPAS36014)
Favorite
(B-061)
(B-061) Utilization of Nationwide Claims Data Mapped to OMOP Common Data Model to Enhance Post-Marketing Drug Safety Studies
Favorite
(B-053)
(B-053) Utilization of pegfilgrastim following health insurance policy interventions: a multi-institutional real-world study in Taiwan
Favorite
(SLC-043)
(SLC-043) Utilization of Real-World Evidence in Drug Approvals at the European Medicines Agency from 2020 to 2023
Favorite
(SLB-028)
(SLB-028) Utilization of Statins and other Lipid-Modifying Agents During Pregnancy in the US, 2005-2021
Favorite
(B-091)
(B-091) Utilization of Type 2 Diabetes Mellitus Products in the Sentinel Distributed Database, 2008-2024
Favorite
(B-138)
(B-138) Utilization of VMAT2 Inhibitors for Tardive Dyskinesia Among Adult Antipsychotic Users
Favorite
(B-136)
(B-136) Utilization Trends of Methadone and Buprenorphine for Opioid Use Disorder in the US Medicaid population
Favorite
V
(B-288)
(B-288) Vaccination for Human Papillomavirus (HPV) and Association with Autonomic Dysfunction and Menstrual Irregularities: A Self-Controlled Case Series Analysis
Favorite
(A-359)
(A-359) Vaccine-related studies listed in the Heads of Medicines Agencies-European Medicines Agency (HMA-EMA) Catalogue of Real-World Data studies: What can we learn from study characteristics?
Favorite
(A-361)
(A-361) Vaccinia vaccine effectiveness against mpox virus infections: a living literature review and evidence synthesis
Favorite
(C-174)
(C-174) Validating Early-stage Cancer Clinical Outcomes for Melanoma and Breast Cancer with Real World Data
Favorite
(A-210)
(A-210) Validation and improvement of an algorithm identifying relapses in multiple sclerosis (MS) within the French nationwide claims database
Favorite
(C-201)
(C-201) Validation of a claims algorithm for identifying patients with Duchenne muscular dystrophy in US administrative claims with genetic laboratory data
Favorite
(B-042)
(B-042) Validation of a claims-based algorithm for body mass index (BMI) and assessment of its utility to balance BMI in active comparator new user studies
Favorite
(B-229)
(B-229) Validation of Diagnostic Codes for Identifying Chlamydial Infections from TriNetX Electronic Health Record Data in the United States
Favorite
(A-292)
(A-292) Validation of Self-Reported Registrations on Maternal Health and Mother-Infant Outcomes: Insights from the BELpREG cohort
Favorite
(SLC-044)
(SLC-044) Validity of German ICD-10-GM Diagnosis Codes for Myocardial Infarction against Chart Review of Electronic Health Records
Favorite
(A-182)
(A-182) Validity of High-Throughput Pharmacoepidemiologic Methods Using Electronic Healthcare Databases for Drug Repurposing Research: Application to Systemic Lupus Erythematosus
Favorite
(B-009)
(B-009) Validity of Hospital Cancer Registry and Electronic Health Record Cancer Diagnoses Among a Large Academic-Community Health System in the United States
Favorite
(B-285)
(B-285) Validity of the International Classification of Diseases 10th Revision Codes for Lithium Toxicity in Adult Patients at Hospital Admission
Favorite
(B-115)
(B-115) Variations in antibiotic use in late premature and term newborns in neonatal care in Sweden 2012-2020
Favorite
(C-196)
(C-196) Varying period prevalence of idiopathic inflammatory myopathies by enrollment factors and case definition: an exploration in a U.S. administrative claims database
Favorite
(A-092)
(A-092) Vitamin K Antagonists And Direct Oral Anticoagulants Are Equal For Recurrent Venous Thromboembolism Prevention In Patients With Anorexia Nervosa: A Nationwide Cohort Study
Favorite
W
(A-086)
(A-086) Weight Changes from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1) Use and Discontinuation: A Retrospective Cohort Study of Electronic Health Records
Favorite
(A-288)
(A-288) What to Expect when You’re Expecting Missing Outcome Data: Development of Claims-Based Algorithms for Pregnancy Identification
Favorite
(A-183)
(A-183) Why We Should Be Prioritizing the Average Treatment Effect on the Treated Over Other Estimands When Evaluating Medical Product Safety
Favorite
Y
(B-121)
(B-121) Yearly Prevalence of Polycystic Ovary Syndrome (PCOS) Diagnosis in the United States and the Uptake of Management Treatment Following Diagnosis in Commercially Insured Women Aged 18-44
Favorite
